Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Winer-Muram, S. Jennings, C. Meyer, Yun Liang, A. Aisen, R. Tarver, R. Mcgarry (2003)
Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations.Radiology, 229 1
S. Aida, H. Shimazaki, Kimiya Sato, M. Sato, H. Deguchi, Y. Ozeki, S. Tamai (2004)
Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar typesHistopathology, 45
C. Moran, L. Hochholzer, N. Fishback, W. Travis, M. Koss (1992)
Mucinous (so-called colloid) carcinomas of lung.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 5 6
Heeseob Lee, J. Goo, Hyun-Jeong Lee, C. Lee, Chi-Hun Park, E. Park, Jung-Gi Im (2009)
Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules.Clinical radiology, 64 2
M. Shapiro, T. Weiser, J. Wisnivesky, Cynthia Chin, Michael Arustamyan, S. Swanson (2009)
Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage I lung cancer.The Journal of thoracic and cardiovascular surgery, 137 6
Daniel Miller, C. Rowland, C. Deschamps, M. Allen, V. Trastek, P. Pairolero (2002)
Surgical treatment of non-small cell lung cancer 1 cm or less in diameter.The Annals of thoracic surgery, 73 5
M. Okada, S. Tauchi, Koichiro Iwanaga, T. Mimura, Yoshitaka Kitamura, Hirokazu Watanabe, S. Adachi, T. Sakuma, C. Ohbayashi (2007)
Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.The Journal of thoracic and cardiovascular surgery, 133 6
N. Kuroda, Nobumasa Hamaguchi, E. Takeuchi, M. Ohara, T. Hirouchi, K. Mizuno (2006)
Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 casesAPMIS, 114
Maoxin Wu, B. Wang, J. Gil, E. Sabo, L. Miller, L. Gan, D. Burstein (2003)
p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.American journal of clinical pathology, 119 5
Y. Yoshida, T. Shibata, A. Kokubu, K. Tsuta, Y. Matsuno, Y. Kanai, H. Asamura, R. Tsuchiya, S. Hirohashi (2005)
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.Lung cancer, 50 1
S. Silver, Frederic Askin (1997)
True papillary carcinoma of the lung: a distinct clinicopathologic entity.The American journal of surgical pathology, 21 1
E. Chaves, Toão Pessoa, O. Campobasso, J. Chrétien, L. Hochholzer, L. Kreyberg, M. Matthews, P. Miřejovský, I. Olchovskaya, G. Riotton, R. Seal, K. Shanmugaratnam, Y. Shimosato, L. Sobin, H. Spencer, R. Yesner, L. Zettergren, M. Amorim, H. Brandt, R. Camain., J. Delarue, H. Hamperl, L. Haranghy, E. Letterer, A. Liebow, J. Mcdonald, E. Pantangco, V. Ramalingswami, R. Seldam, A. Strukov, A. Thackray, J. Thomson, H. Torloni, E. Uehlinger, H. Ungar (1981)
Histological Typing of Lung Tumours 1Tumori Journal, 67
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)
Global cancer statisticsCA: A Cancer Journal for Clinicians, 61
S. Lau, Matthew Desrochers, D. Luthringer (2002)
Expression of Thyroid Transcription Factor-1, Cytokeratin 7, and Cytokeratin 20 in Bronchioloalveolar Carcinomas: an Immunohistochemical Evaluation of 67 CasesModern Pathology, 15
Y. Ohde, K. Nagai, J. Yoshida, M. Nishimura, Kenro Takahashi, Kenji Suzuki, K. Takamochi, T. Yokose, Y. Nishiwaki (2003)
The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocarcinoma.Lung cancer, 42 3
D. Raz, Biao He, R. Rosell, D. Jablons (2006)
Bronchioloalveolar carcinoma: a review.Clinical lung cancer, 7 5
M. Vazquez, D. Carter, E. Brambilla, A. Gazdar, M. Noguchi, W. Travis, Yao Huang, Lijuan Zhang, R. Yip, D. Yankelevitz, C. Henschke (2009)
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.Lung cancer, 64 2
C. Chantranuwat, V. Sriuranpong, N. Huapai, T. Chalermchai, K. Leungtaweeboon, N. Voravud, A. Mutirangura (2005)
Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 88 Suppl 4
Yusuke Nakamura, T. Niki, A. Goto, Teppei Morikawa, K. Miyazawa, J. Nakajima, M. Fukayama (2007)
c‐Met activation in lung adenocarcinoma tissues: An immunohistochemical analysisCancer Science, 98
N. Kuroda, T. Hamauzu, M. Toi, K. Yamaoka, E. Miyazaki, M. Hiroi, H. Nakata, H. Taguchi, H. Enzan (2005)
Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical studyAPMIS, 113
Ken-ichi Watanabe, H. Nomori, T. Ohtsuka, T. Naruke, A. Ebihara, H. Orikasa, K. Yamazaki, K. Uno, Toshiaki Kobayashi, T. Goya (2006)
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.Japanese journal of clinical oncology, 36 7
W. Travis, K. Garg, W. Franklin, I. Wistuba, B. Sabloff, M. Noguchi, R. Kakinuma, M. Zakowski, M. Ginsberg, R. Padera, F. Jacobson, B. Johnson, F. Hirsch, E. Brambilla, D. Flieder, K. Geisinger, Frederik Thunnisen, K. Kerr, D. Yankelevitz, T. Franks, J. Galvin, D. Henderson, A. Nicholson, P. Hasleton, V. Roggli, M. Tsao, F. Cappuzzo, M. Vazquez (2005)
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 14
(2010)
Expression of squamous markers in lung adenocarcinoma (AD): clinicopathologic and molecular correlates, and implications for differentiation from squamous cell carcinoma (SqCC)
L. Ding, G. Getz, D. Wheeler, E. Mardis, M. McLellan, K. Cibulskis, C. Sougnez, H. Greulich, D. Muzny, M. Morgan, L. Fulton, R. Fulton, Qunyuan Zhang, M. Wendl, M. Lawrence, D. Larson, Ken Chen, D. Dooling, A. Sabo, A. Hawes, Hua Shen, S. Jhangiani, L. Lewis, O. Hall, Yiming Zhu, T. Mathew, Yanru Ren, Jiqiang Yao, S. Scherer, Kerstin Clerc, G. Metcalf, Brian Ng, A. Milosavljevic, M. Gonzalez-Garay, John Osborne, R. Meyer, Xiaoqi Shi, Yuzhu Tang, D. Koboldt, Ling Lin, R. Abbott, T. Miner, C. Pohl, G. Fewell, C. Haipek, Heather Schmidt, Brian Dunford-Shore, A. Kraja, S. Crosby, Christopher Sawyer, T. Vickery, Sacha Sander, J. Robinson, W. Winckler, J. Baldwin, L. Chirieac, A. Dutt, T. Fennell, M. Hanna, B. Johnson, R. Onofrio, Roman Thomas, G. Tonon, B. Weir, Xiaojun Zhao, L. Ziaugra, M. Zody, T. Giordano, M. Orringer, J. Roth, M. Spitz, I. Wistuba, B. Ozenberger, P. Good, A. Chang, D. Beer, M. Watson, M. Ladanyi, S. Broderick, A. Yoshizawa, W. Travis, W. Pao, M. Province, G. Weinstock, H. Varmus, S. Gabriel, E. Lander, R. Gibbs, M. Meyerson, R. Wilson (2008)
Somatic mutations affect key pathways in lung adenocarcinomaNature, 455
Zhi-gang Yang, S. Sone, S. Takashima, Feng Li, T. Honda, Y. Maruyama, M. Hasegawa, S. Kawakami (2001)
High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT.AJR. American journal of roentgenology, 176 6
Ryo Maeda, N. Isowa, H. Onuma, H. Miura, Tomoya Harada, Hirokazu Touge, H. Tokuyasu, Y. Kawasaki (2009)
Lung adenocarcinomas with micropapillary componentsGeneral Thoracic and Cardiovascular Surgery, 57
S. Takashima, Y. Maruyama, M. Hasegawa, T. Yamanda, T. Honda, M. Kadoya, S. Sone (2002)
Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients.Lung cancer, 36 3
Kimihide Yoshida, Y. Yatabe, J. Park, J. Shimizu, Y. Horio, K. Matsuo, T. Kosaka, T. Mitsudomi, T. Hida (2007)
Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung CancerJournal of Thoracic Oncology, 2
Ricardo Camilo, V. Capelozzi, S. Siqueira, F. Bernardi (2006)
Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.Human pathology, 37 5
F. Cappuzzo, P. Jänne, M. Skokan, G. Finocchiaro, E. Rossi, C. Ligorio, P. Zucali, L. Terracciano, L. Toschi, M. Roncalli, A. Destro, M. Incarbone, M. Alloisio, A. Santoro, M. Varella-Garcia (2009)
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.Annals of oncology : official journal of the European Society for Medical Oncology, 20 2
Y. Yatabe, T. Koga, T. Mitsudomi, Takashi Takahashi (2004)
CK20 expression, CDX2 expression, K‐ras mutation, and goblet cell morphology in a subset of lung adenocarcinomasThe Journal of Pathology, 203
K. Okudela, Tetsukan Woo, Hideaki Mitsui, T. Yazawa, H. Shimoyamada, M. Tajiri, N. Ogawa, M. Masuda, H. Kitamura (2010)
Proposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease.International journal of clinical and experimental pathology, 3 4
G. Sica, A. Yoshizawa, C. Sima, C. Azzoli, R. Downey, V. Rusch, W. Travis, A. Moreira (2010)
A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsThe American Journal of Surgical Pathology, 34
J. Bishop, Rajni Sharma, P. Illei (2010)
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.Human pathology, 41 1
J. Paez, P. Jänne, Jeffrey Lee, Sean Tracy, H. Greulich, S. Gabriel, P. Herman, F. Kaye, N. Lindeman, T. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M. Eck, W. Sellers, B. Johnson, M. Meyerson (2004)
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 304
B. Shrestha, Y. Ebihara, Y. Osakabe, H. Kato (1998)
Immunohistochemical, ultrastructural and molecular study of well differentiated adenocarcinomas of the lung predominantly composed of goblet cells.Lung cancer, 22 2
D. Garfield, J. Cadranel (2009)
The Importance of Distinguishing Mucinous and Nonmucinous Bronchioloalveolar CarcinomasLung, 187
H. Nakayama, M. Noguchi, R. Tsuchiya, T. Kodama, Y. Shimosato (1990)
Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 3 3
M. Balak, Y. Gong, Gregory Riely, R. Somwar, Allan Li, M. Zakowski, Anne Chiang, Guangli Yang, O. Ouerfelli, M. Kris, M. Ladanyi, V. Miller, W. Pao (2006)
Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase InhibitorsClinical Cancer Research, 12
R. Rosell, L. Pérez-Roca, J. Sánchez, M. Cobo, T. Morán, I. Chaib, M. Provencio, M. Dómine, M. Sala, U. Jiménez, P. Diz, I. Barneto, J. Macías, R. Peñas, S. Catot, D. Isla, J. Sánchez, R. Ibeas, G. López-Vivanco, J. Oramas, P. Méndez, N. Reguart, R. Blanco, M. Taron (2009)
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA ExpressionPLoS ONE, 4
K. Higashi, Y. Ueda, Koichi Ayabe, A. Sakurai, H. Seki, Y. Nambu, M. Oguchi, H. Shikata, S. Taki, H. Tonami, S. Katsuda, I. Yamamoto (2000)
FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological featuresNuclear Medicine Communications, 21
D. Jackman, A. Holmes, N. Lindeman, P. Wen, S. Kesari, A. Borras, Christopher Bailey, F. Jong, P. Jänne, B. Johnson (2006)
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 27
G. Scagliotti, N. Hanna, F. Fossella, K. Sugarman, J. Blatter, P. Peterson, L. Simms, F. Shepherd (2009)
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.The oncologist, 14 3
M. Raponi, Lesley Dossey, T. Jatkoe, Xiaoying Wu, Guoan Chen, H. Fan, D. Beer (2009)
MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.Cancer research, 69 14
K. Finberg, L. Sequist, V. Joshi, A. Muzikansky, Julie Miller, Moonjoo Han, J. Beheshti, L. Chirieac, E. Mark, A. Iafrate (2007)
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.The Journal of molecular diagnostics : JMD, 9 3
W. Pao, V. Miller, K. Politi, Gregory Riely, R. Somwar, M. Zakowski, M. Kris, H. Varmus (2005)
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLoS Medicine, 2
F. Hirsch, M. Varella-Garcia, P. Bunn, W. Franklin, R. Dziadziuszko, N. Thatcher, A. Chang, P. Parikh, J. Pereira, T. Ciuleanu, J. Pawel, C. Watkins, Angela Flannery, G. Ellison, E. Donald, Lucy Knight, D. Parums, N. Botwood, B. Holloway (2006)
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 31
K. Murase, Y. Yasuhara, J. Ikezoe, K. Eguchi, H. Mogami, K. Mandai, Y. Ooshiro (2002)
Measurement of Localized Ground-Glass Attenuation on Thin-Section Computed Tomography Images: Correlation With the Progression of Bronchioloalveolar Carcinoma of the LungInvestigative Radiology, 37
R. Ginsberg, L. Rubinstein (1995)
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.The Annals of thoracic surgery, 60 3
Futoshi Ishiguro, K. Matsuo, T. Fukui, S. Mori, S. Hatooka, T. Mitsudomi (2010)
Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.The Journal of thoracic and cardiovascular surgery, 139 4
R. Klaveren, M. Oudkerk, M. Prokop, E. Scholten, K. Nackaerts, R. Vernhout, C. Iersel, K. Bergh, S. Westeinde, C. Aalst, E. Thunnissen, Dong Xu, Ying Wang, Yingru Zhao, H. Gietema, B. Hoop, H. Groen, G. Bock, P. Ooijen, C. Weenink, J. Verschakelen, J. Lammers, W. Timens, D. Willebrand, A. Vink, W. Mali, H. Koning (2009)
Management of lung nodules detected by volume CT scanning.The New England journal of medicine, 361 23
J. Austin, A. Mujoomdar, C. Powell, G. Pearson, H. Raftopoulos (2008)
Carcinoma of the lung and metastatic disease of the central nervous system.American journal of respiratory and critical care medicine, 178 10
T. Ohtsuka, H. Nomori, Kenichi Watanabe, M. Kaji, T. Naruke, K. Suemasu, K. Uno (2006)
Prognostic significance of [18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinomaCancer, 107
L. Sequist, D. Bell, T. Lynch, D. Haber (2007)
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 5
(2010)
Subtyping of non-small cell lung carcinoma (NSCLC): comparison of cytology and small biopsy specimens
R. Nishio, S. Akata, Kazuhiro Saito, T. Ohira, M. Tsuboi, T. Hirano, N. Ikeda, F. Kotake, H. Kato, K. Abe (2007)
The Ratio of the Maximum High Attenuation Area Dimension to the Maximum Tumor Dimension May Be an Index of the Presence of Lymph Node Metastasis in Lung Adenocarcinomas 3 cm or Smaller on High-Resolution Computed TomographyJournal of Thoracic Oncology, 2
A. Simsir, Xiao-Jun Wei, H. Yee, A. Moreira, J. Cangiarella (2004)
Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.American journal of clinical pathology, 121 3
A. Maeshima, N. Tochigi, A. Yoshida, H. Asamura, K. Tsuta, H. Tsuda (2010)
Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic IndicatorJournal of Thoracic Oncology, 5
Y. Nakatani, K. Masudo, Y. Miyagi, Y. Inayama, N. Kawano, Yukichi Tanaka, Keisuke Kato, Takaaki Ito, H. Kitamura, Y. Nagashima, S. Yamanaka, N. Nakamura, J. Sano, N. Ogawa, N. Ishiwa, K. Notohara, M. Rešl, E. Mark (2002)
Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form MorulesModern Pathology, 15
A. Maeshima, N. Tochigi, A. Yoshida, H. Asamura, K. Tsuta, H. Tsuda (2010)
Clinicopathologic Analysis of Multiple (Five or More) Atypical Adenomatous Hyperplasias (AAHs) of the Lung: Evidence for the AAH-Adenocarcinoma SequenceJournal of Thoracic Oncology, 5
K. Kuriyama, M. Seto, T. Kasugai, M. Higashiyama, S. Kido, Y. Sawai, K. Kodama, C. Kuroda (1999)
Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung.AJR. American journal of roentgenology, 173 2
Marcel Rens, E. Eijken, J. Elbers, Jan-Willem Lammers, M. Tilanus, P. Slootweg (2002)
p53 mutation analysis for definite diagnosis of multiple primary lung carcinomaCancer, 94
P. Glasziou (2008)
GRADE: assessing the quality of evidence for diagnostic recommendationsEvidence Based Medicine, 13
R. Zinner, S. Novello, G. Peng, R. Herbst, C. Obasaju, G. Scagliotti (2010)
Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials.Clinical lung cancer, 11 2
大谷 弘樹 (2008)
Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients
Xi Wang, D. Christiani, E. Mark, Heather Nelson, J. Wiencke, L. Gunn, J. Wain, K. Kelsey (1999)
Carcinogen exposure, p53 alteration, and K‐ras mutation in synchronous multiple primary lung carcinomaCancer, 85
Donghui Li, Jeffrey Morris, Jun Liu, Manal Hassan, R. Day, Melissa Bondy, J. Abbruzzese (2009)
F1000 highlightsAsia‐Pacific Journal of Clinical Oncology, 5
Hsuan-Yu Chen, Sung-Liang Yu, Chun-Houh Chen, G. Chang, Chih‐Yi Chen, A. Yuan, Chiou-Ling Cheng, Chien-Hsun Wang, H. Terng, S. Kao, Wing-Kai Chan, Han-Ni Li, Chun-Chi Liu, Sher Singh, Wei Chen, Jeremy Chen, Pan‐Chyr Yang (2007)
A five-gene signature and clinical outcome in non-small-cell lung cancer.The New England journal of medicine, 356 1
V. Miller, Gregory Riely, M. Zakowski, Allan Li, J. Patel, R. Heelan, M. Kris, A. Sandler, D. Carbone, A. Tsao, R. Herbst, G. Heller, M. Ladanyi, W. Pao, David Johnson (2008)
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 9
K. Inamura, T. Shimoji, H. Ninomiya, M. Hiramatsu, M. Okui, Y. Satoh, S. Okumura, K. Nakagawa, T. Noda, M. Fukayama, Y. Ishikawa (2007)
A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity.Human pathology, 38 5
D. Garfield, W. Franklin (2008)
A Comparison of Survival and Disease‐Specific Survival in Surgically Resected, Lymph Node‐Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant TherapyCancer, 113
R. Daly, V. Trastek, P. Pairolero, P. Murtaugh, Mingdi Huang, M. Allen, T. Colby (1991)
Bronchoalveolar carcinoma: factors affecting survival.The Annals of thoracic surgery, 51 3
Ho Lee, Joungho Han, K. Lee, J. Koo, S. Jeong, Byung‐Tae Kim, Y. Cho, Y. Shim, Jhingook Kim, Kwanmien Kim, Y. Choi (2009)
Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings.Lung cancer, 66 3
C. Henschke, D. Yankelevitz, D. Libby, M. Pasmantier, James Smith, O. Miettinen (2006)
Survival of patients with stage I lung cancer detected on CT screening.The New England journal of medicine, 355 17
Amgad El-Sherif, W. Gooding, R. Santos, B. Pettiford, P. Ferson, H. Fernando, S. Urda, J. Luketich, R. Landreneau (2006)
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.The Annals of thoracic surgery, 82 2
H. Kitamura, Y. Kameda, Takaaki Ito, H. Hayashi (1999)
Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma.American journal of clinical pathology, 111 5
N. Motoi, J. Szőke, Gregory Riely, V. Seshan, M. Kris, V. Rusch, W. Gerald, W. Travis (2008)
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression AnalysisThe American Journal of Surgical Pathology, 32
G. Guyatt, A. Oxman, R. Kunz, G. Vist, Y. Falck-Ytter, H. Schünemann (2008)
What is “quality of evidence” and why is it important to clinicians?BMJ : British Medical Journal, 336
Siu‐Yuhe Weng, Eiju Tsuchiya, Yukitoshi Satoh, Tomoyuki Kitagawa, Ken Nakagawa, Haruo Sugano (1990)
Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo‐alveolar carcinomaHistopathology, 16
M. Fukuoka, Yi-long Wu, S. Thongprasert, Chih‐Hsin Yang, D. Chu, N. Saijo, C. Watkins, E. Duffield, A. Armour, T. Mok (2009)
Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
H. Macmahon (2010)
Compliance with Fleischner Society guidelines for management of lung nodules: lessons and opportunities.Radiology, 255 1
M. Schuchert, B. Pettiford, S. Keeley, T. d’Amato, A. Kilic, J. Close, A. Pennathur, R. Santos, H. Fernando, J. Landreneau, J. Luketich, R. Landreneau (2007)
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.The Annals of thoracic surgery, 84 3
M. Yano, H. Sasaki, Y. Kobayashi, H. Yukiue, H. Haneda, E. Suzuki, K. Endo, O. Kawano, M. Hara, Y. Fujii (2006)
Epidermal Growth Factor Receptor Gene Mutation and Computed Tomographic Findings in Peripheral Pulmonary AdenocarcinomaJournal of Thoracic Oncology, 1
T. Ciuleanu, T. Brodowicz, C. Zielinski, J. Kim, M. Krzakowski, E. Laack, Yi-long Wu, I. Bover, StephenD. Begbie, V. Tzekova, B. Čučević, J. Pereira, S. Yang, J. Madhavan, K. Sugarman, P. Peterson, W. John, K. Krejcy, C. Belani (2009)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 studyThe Lancet, 374
U. Pastorino, C. Landoni, A. Marchiano, E. Calabró, G. Sozzi, R. Miceli, M. Picchio, L. Mariani, C. Messa, F. Fazio (2009)
Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy SmokersJournal of Thoracic Oncology, 4
T. Kim, J. Goo, K. Lee, C. Park, H. Lee (2009)
Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.Lung cancer, 64 2
M. Ikehara, H. Saito, T. Kondo, S. Murakami, H. Ito, M. Tsuboi, F. Oshita, K. Noda, H. Nakayama, T. Yokose, Y. Kameda, Kouzo Yamada (2012)
Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findings.European journal of radiology, 81 1
R. Eisenberg, A. Bankier, P. Boiselle (2010)
Compliance with Fleischner Society guidelines for management of small lung nodules: a survey of 834 radiologists.Radiology, 255 1
Zhe Tang, Runlei Du, Shan Jiang, Chunying Wu, Deborah Barkauskas, John Richey, J. Molter, M. Lam, C. Flask, S. Gerson, A. Dowlati, Lili Liu, Z. Lee, B. Halmos, Yanming Wang, J. Kern, P. Ma (2008)
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancerBritish Journal of Cancer, 99
N. Girard, C. Deshpande, C. Azzoli, V. Rusch, W. Travis, M. Ladanyi, W. Pao (2010)
Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.Chest, 137 1
J. Im, M. Han, E. Yu, J. Han, J. Park, C. Kim, Jong Seo, Y. Yoon, Jong Lee, Kyung Lee (1990)
Lobar bronchioloalveolar carcinoma: "angiogram sign" on CT scans.Radiology, 176 3
A. Borczuk, H. Kim, H. Yegen, R. Friedman, C. Powell (2005)
Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.American journal of respiratory and critical care medicine, 172 6
E. Steels, M. Paesmans, T. Berghmans, F. Branle, F. Lemaitre, C. Mascaux, A. Meert, F. Vallot, J. Lafitte, J. Sculier (2001)
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.The European respiratory journal, 18 4
J. Douillard, F. Shepherd, V. Hirsh, T. Mok, M. Socinski, R. Gervais, M. Liao, H. Bischoff, M. Reck, M. Sellers, C. Watkins, G. Speake, A. Armour, Edward Kim (2010)
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 5
K. Tamura, I. Okamoto, T. Kashii, S. Negoro, T. Hirashima, S. Kudoh, Y. Ichinose, N. Ebi, K. Shibata, T. Nishimura, N. Katakami, T. Sawa, E. Shimizu, Junya Fukuoka, T. Satoh, M. Fukuoka (2008)
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)British Journal of Cancer, 98
G. Pelosi, A. Sonzogni, G. Veronesi, E. Camilli, P. Maisonneuve, L. Spaggiari, M. Manzotti, M. Masullo, G. Taliento, C. Fumagalli, M. Bellomi, W. Travis, M. Kadivar, G. Viale (2008)
Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.Lung cancer, 62 2
P. Shah, Suveer Singh, M. Bower, N. Livni, S. Padley, A. Nicholson (2006)
The Role of Transbronchial Fine Needle Aspiration in an Integrated Care Pathway for the Assessment of Patients with Suspected Lung CancerJournal of Thoracic Oncology, 1
(1970)
Cancer Incidence in Five Continents
D. Gleason (1992)
Histologic grading of prostate cancer: a perspective.Human pathology, 23 3
J. Marks, S. Broderick, Qin Zhou, D. Chitale, Allan Li, M. Zakowski, M. Kris, V. Rusch, C. Azzoli, V. Seshan, M. Ladanyi, W. Pao (2008)
Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung AdenocarcinomaJournal of Thoracic Oncology, 3
(2011)
Testing of new IASLC/ATS/ERS criteria for diagnosis of lung adenocarcinoma (AD) in small biopsies: minimize immunohistochemistry (IHC) to maximize tissue for molecular studies
L. Xi, James Lyons-Weiler, M. Coello, Xin Huang, W. Gooding, J. Luketich, T. Godfrey (2005)
Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung AdenocarcinomasClinical Cancer Research, 11
G. Sarantopoulos, D. Gui, P. Shintaku, Longsheng Hong, Ya-Ying Wang, C. Yap, M. Fishbein (2004)
Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.Archives of pathology & laboratory medicine, 128 4
J. Yoshida, K. Nagai, T. Yokose, M. Nishimura, R. Kakinuma, H. Ohmatsu, Y. Nishiwaki (2005)
Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.The Journal of thoracic and cardiovascular surgery, 129 5
L. Sholl, Yun Xiao, V. Joshi, B. Yeap, L. Cioffredi, D. Jackman, Charles Lee, P. Jänne, N. Lindeman (2010)
EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.American journal of clinical pathology, 133 6
C. Henschke, D. McCauley, D. Yankelevitz, D. Naidich, G. McGuinness, O. Miettinen, D. Libby, M. Pasmantier, J. Koizumi, N. Altorki, James Smith (1999)
Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 354
L. Sequist, R. Martins, D. Spigel, S. Grunberg, A. Spira, P. Jänne, V. Joshi, D. Mccollum, T. Evans, A. Muzikansky, Georgiana Kuhlmann, Moon Han, Jonathan Goldberg, J. Settleman, A. Iafrate, J. Engelman, D. Haber, B. Johnson, T. Lynch (2008)
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 15
V. Monica, P. Ceppi, L. Righi, Veronica Tavaglione, M. Volante, G. Pelosi, G. Scagliotti, M. Papotti (2009)
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lungModern Pathology, 22
M. Sonobe, T. Manabe, H. Wada, F. Tanaka (2006)
Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain.The Journal of molecular diagnostics : JMD, 8 3
V. Monica, G. Scagliotti, P. Ceppi, L. Righi, A. Cambieri, Marco Iacono, S. Saviozzi, M. Volante, S. Novello, M. Papotti (2009)
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the LungClinical Cancer Research, 15
Tsuyoshi Takahashi, M. Sonobe, Masashi Kobayashi, A. Yoshizawa, T. Menju, E. Nakayama, N. Mino, Shotaro Iwakiri, Kiyoshi Sato, R. Miyahara, K. Okubo, T. Manabe, H. Date (2010)
Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion GeneAnnals of Surgical Oncology, 17
D. Parkin, F. Bray, J. Ferlay, P. Pisani (2005)
Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 55
N. Au, A. Gown, Maggie Cheang, D. Huntsman, E. Yorida, W. Elliott, J. Flint, J. English, C. Gilks, H. Grimes (2004)
p63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 CasesApplied Immunohistochemistry & Molecular Morphology, 12
F. Cappuzzo, F. Hirsch, E. Rossi, S. Bartolini, G. Ceresoli, L. Bemis, J. Haney, S. Witta, K. Danenberg, I. Domenichini, V. Ludovini, E. Magrini, V. Gregorc, C. Doglioni, A. Sidoni, M. Tonato, W. Franklin, L. Crinò, P. Bunn, M. Varella-Garcia (2005)
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.Journal of the National Cancer Institute, 97 9
A. Sutani, Y. Nagai, K. Udagawa, Y. Uchida, N. Koyama, Y. Murayama, Tomoaki Tanaka, H. Miyazawa, Michio Nagata, M. Kanazawa, K. Hagiwara, Kiyoko Kobayashi (2006)
Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clampBritish Journal of Cancer, 95
T. Kondo, Kouzo Yamada, K. Noda, H. Nakayama, Y. Kameda (2002)
Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas.Lung cancer, 36 1
Kenji Suzuki, H. Asamura, M. Kusumoto, H. Kondo, R. Tsuchiya (2002)
"Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.The Annals of thoracic surgery, 74 5
T. Mitsudomi, N. Hamajima, M. Ogawa, Takashi Takahashi (2000)
Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 10
M. Rivera, A. Mehta (2007)
Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).Chest, 132 3 Suppl
H. Matsuguma, K. Yokoi, M. Anraku, T. Kondo, Y. Kamiyama, K. Mori, K. Tominaga, Y. Tsuura, S. Honjo (2002)
Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.The Journal of thoracic and cardiovascular surgery, 124 2
A. Meert, B. Martin, P. Delmotte, T. Berghmans, J. Lafitte, C. Mascaux, M. Paesmans, E. Steels, J. Verdebout, J. Sculier (2002)
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisEuropean Respiratory Journal, 20
J. Cataluña, M. Perpin̄á, J. Greses, V. Calvo, J. Padilla, F. París (1996)
Cell type accuracy of bronchial biopsy specimens in primary lung cancer.Chest, 109 5
W. Westra, I. Baas, R. Hruban, F. Askin, Kiersten Wilson, G. Offerhaus, R. Slebos (1996)
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.Cancer research, 56 9
L. Tanoue (2009)
Evaluation of Patients with Pulmonary Nodules: When is it Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)Yearbook of Medicine, 2009
Y. Ohno, H. Hatabu, D. Takenaka, H. Uematsu, C. Ohbayashi, T. Higashino, M. Nogami, M. Yoshimura, M. Fujii, K. Sugimura (2004)
Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung.European journal of radiology, 52 2
J. Furák, I. Troján, T. Szőke, L. Tiszlavicz, Z. Morvay, J. Eller, Á. Balogh (2003)
Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 23 5
M. Noguchi, A. Morikawa, M. Kawasaki, Y. Matsuno, T. Yamada, S. Hirohashi, H. Kondo, Y. Shimosato (1995)
Small adenocarcinoma of the lung. Histologic characteristics and prognosisCancer, 75
J. Soh, S. Toyooka, Shuji Ichihara, Hiroaki Asano, N. Kobayashi, Hiroshi Suehisa, H. Otani, H. Yamamoto, K. Ichimura, K. Kiura, A. Gazdar, H. Date (2008)
Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the LungJournal of Thoracic Oncology, 3
Roberta Miller (1990)
Bronchioloalveolar Cell AdenomasThe American Journal of Surgical Pathology, 14
M. Nakata, S. Sawada, H. Saeki, S. Takashima, H. Mogami, N. Teramoto, K. Eguchi (2003)
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography.The Annals of thoracic surgery, 75 5
K. Hatanaka, K. Tsuta, Katsuya Watanabe, K. Sugino, T. Uekusa (2011)
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7.Pathology, research and practice, 207 3
C. Kang, B. Jang, Dong-Wan Kim, D. Chung, Y. Kim, S. Jheon, S. Sung, Joo Kim (2010)
The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection.Lung cancer, 68 3
R. Tanaka, H. Horikoshi, Y. Nakazato, Erina Seki, K. Minato, M. Iijima, M. Kojima, T. Goya (2009)
Magnetic Resonance Imaging in Peripheral Lung Adenocarcinoma: Correlation With Histopathologic FeaturesJournal of Thoracic Imaging, 24
T. Nakazono, Y. Sakao, K. Yamaguchi, S. Imai, H. Kumazoe, Shoichiro Kudo (2005)
Subtypes of peripheral adenocarcinoma of the lung: differentiation by thin-section CTEuropean Radiology, 15
Shun-ichi Watanabe, Toshio Watanabe, K. Arai, T. Kasai, J. Haratake, H. Urayama (2002)
Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography.The Annals of thoracic surgery, 73 4
U. Tateishi, H. Uno, K. Yonemori, M. Satake, M. Takeuchi, Y. Arai (2005)
Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis.Chest, 128 5
G. Stenhouse, N. Fyfe, G. King, A. Chapman, K. Kerr (2004)
Thyroid transcription factor 1 in pulmonary adenocarcinomaJournal of Clinical Pathology, 57
S. Solomon, M. Zakowski, W. Pao, R. Thornton, M. Ladanyi, M. Kris, V. Rusch, N. Rizvi (2010)
Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis.AJR. American journal of roentgenology, 194 1
O. Auerbach (1968)
Histological Typing Of Lung TumorsThe Annals of Thoracic Surgery, 5
H. Shim, I. Park, Chang Lee, K. Chung (2009)
Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer.Lung cancer, 65 2
S. Mills (2012)
Histology for Pathologists
T. Mitsudomi, S. Morita, Y. Yatabe, S. Negoro, I. Okamoto, J. Tsurutani, T. Seto, M. Satouchi, H. Tada, T. Hirashima, K. Asami, N. Katakami, M. Takada, H. Yoshioka, K. Shibata, S. Kudoh, E. Shimizu, H. Saito, S. Toyooka, K. Nakagawa, M. Fukuoka (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.The Lancet. Oncology, 11 2
Koei Ikeda, K. Awai, Takeshi Mori, Koichi Kawanaka, Y. Yamashita, H. Nomori (2007)
Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification.Chest, 132 3
S. Sone, T. Nakayama, T. Honda, K. Tsushima, Feng Li, M. Haniuda, Yoshiro Takahashi, Takaichiro Suzuki, T. Yamanda, R. Kondo, T. Hanaoka, F. Takayama, K. Kubo, Hajime Fushimi (2007)
Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.Lung cancer, 58 3
U. Tateishi, N. Müller, T. Johkoh, Arafumi Maeshima, H. Asamura, M. Satake, M. Kusumoto, Y. Arai (2005)
Mucin-Producing Adenocarcinoma of the Lung: Thin-Section Computed Tomography Findings in 48 Patients and Their Effect on PrognosisJournal of Computer Assisted Tomography, 29
Y. Janjigian, K. McDonnell, M. Kris, R. Shen, C. Sima, P. Bach, N. Rizvi, Gregory Riely (2010)
Pack‐years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancerCancer, 116
M. Gould, J. Fletcher, M. Iannettoni, W. Lynch, D. Midthun, D. Naidich, D. Ost (2007)
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).Chest, 132 3 Suppl
I. Yoshino, R. Nakanishi, T. Osaki, S. Hasuda, S. Taga, M. Takenoyama, T. Yoshimatsu, K. Yasumoto (1997)
Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.The Annals of thoracic surgery, 64 3
Y. Yoshida, A. Kokubu, Kenji Suzuki, Hidehiko Kuribayashi, K. Tsuta, Y. Matsuno, M. Kusumoto, Y. Kanai, H. Asamura, S. Hirohashi, T. Shibata (2007)
Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.Japanese journal of clinical oncology, 37 12
Hiroaki Asano, S. Toyooka, Masaki Tokumo, K. Ichimura, K. Aoe, Sachio Ito, K. Tsukuda, M. Ouchida, M. Aoe, H. Katayama, A. Hiraki, K. Sugi, K. Kiura, H. Date, N. Shimizu (2006)
Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction AssayClinical Cancer Research, 12
D. Garfield, J. Cadranel, H. West (2008)
Bronchioloalveolar carcinoma: the case for two diseases.Clinical lung cancer, 9 1
T. Lynch, D. Bell, Raffaella Sordella, S. Gurubhagavatula, R. Okimoto, Brian Brannigan, Patricia Harris, Sara Haserlat, J. Supko, F. Haluska, D. Louis, D. Christiani, J. Settleman, D. Haber (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.The New England journal of medicine, 350 21
M. Gaeta, A. Blandino, E. Scribano, G. Ascenti, F. Minutoli, I. Pandolfo (1999)
Mucinous cystadenocarcinoma of the lung: CT-pathologic correlation in three cases.Journal of computer assisted tomography, 23 4
M. Riquet, C. Foucault, P. Berna, J. Assouad, A. Dujon, C. Danel (2006)
Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.The Annals of thoracic surgery, 81 6
Shang-Gin Wu, C. Gow, Chong-Jen Yu, Yih-Leong Chang, Chih‐Hsin Yang, Y-C Hsu, J. Shih, Yung-Chie Le, Pan‐Chyr Yang (2008)
Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma
Eiichi Sawada, A. Nambu, U. Motosugi, T. Araki, S. Kato, Yoko Sato, A. Saito, H. Ishihara, H. Okuwaki, K. Ozawa, K. Nishikawa, M. Miyazawa, K. Miyata (2010)
Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findingsJapanese Journal of Radiology, 28
N. Girard, C. Deshpande, C. Lau, D. Finley, V. Rusch, W. Pao, W. Travis (2009)
Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From MetastasesThe American Journal of Surgical Pathology, 33
J. Manning, H. Spjut, J. Tschen (1984)
Bronchioloalveolar carcinoma: The significance of two histopathologic typesCancer, 54
P. Chu, L. Weiss (2002)
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 CasesModern Pathology, 15
N. Girard, I. Ostrovnaya, C. Lau, Bernard Park, M. Ladanyi, D. Finley, C. Deshpande, V. Rusch, I. Orlow, W. Travis, W. Pao, C. Begg (2009)
Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung CancersClinical Cancer Research, 15
J. Engelman, K. Zejnullahu, T. Mitsudomi, Youngchul Song, Courtney Hyland, Joon-Oh Park, N. Lindeman, Christopher-Michael Gale, Xiaojun Zhao, J. Christensen, T. Kosaka, A. Holmes, A. Rogers, F. Cappuzzo, T. Mok, Charles Lee, B. Johnson, L. Cantley, P. Jänne (2007)
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 316
J. Larsen, S. Pavey, Linda Passmore, R. Bowman, N. Hayward, K. Fong (2007)
Gene Expression Signature Predicts Recurrence in Lung AdenocarcinomaClinical Cancer Research, 13
P. McMahon, C. Kong, B. Johnson, M. Weinstein, J. Weeks, Karen Kuntz, Karen Kuntz, J. Shepard, S. Swensen, G. Gazelle (2008)
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.Radiology, 248 1
T. Koga, S. Hashimoto, K. Sugio, I. Yoshino, S. Mojtahedzadeh, Y. Matsuo, Y. Yonemitsu, K. Sugimachi, K. Sueishi (2001)
Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 6
H. Endoh, S. Tomida, Y. Yatabe, H. Konishi, H. Osada, K. Tajima, H. Kuwano, Takashi Takahashi, T. Mitsudomi (2004)
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 5
N. Hanna, F. Shepherd, F. Fossella, J. Pereira, F. Marinis, J. Pawel, U. Gatzemeier, T. Tsao, M. Pless, T. Muller, H. Lim, C. Desch, K. Szondy, R. Gervais, Shaharyar, C. Manegold, S. Paul, P. Paoletti, L. Einhorn, P. Bunn (2004)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 9
A. Kargı, Duygu Gurel, B. Tuna (2007)
The Diagnostic Value of TTF-1, CK 5/6, and p63 Immunostaining in Classification of Lung CarcinomasApplied Immunohistochemistry & Molecular Morphology, 15
M. Sagawa, K. Higashi, M. Sugita, Y. Ueda, S. Maeda, H. Toga, T. Sakuma (2005)
Fluorodeoxyglucose Uptake Correlates with the Growth Pattern of Small Peripheral Pulmonary AdenocarcinomaSurgery Today, 36
J. Barletta, S. Perner, A. Iafrate, B. Yeap, B. Weir, L. Johnson, B. Johnson, M. Meyerson, M. Rubin, W. Travis, M. Loda, L. Chirieac (2009)
Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma, 13
S. Dacic, D. Ionescu, S. Finkelstein, S. Yousem (2005)
Patterns of Allelic Loss of Synchronous Adenocarcinomas of the LungThe American Journal of Surgical Pathology, 29
D. Lin, Y. Ma, S. Zheng, X-Y Liu, S. Zou, W.-q. Wei (2006)
Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma.Histology and histopathology, 21 6
M. Nakata, S. Sawada, M. Yamashita, H. Saeki, A. Kurita, S. Takashima, K. Tanemoto (2004)
Surgical treatments for multiple primary adenocarcinoma of the lung.The Annals of thoracic surgery, 78 4
Y. Yatabe, Takashi Takahashi, T. Mitsudomi (2008)
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.Cancer research, 68 7
W. Westra (2000)
Early glandular neoplasia of the lungRespiratory Research, 1
H. Tsutsumida, M. Nomoto, M. Goto, S. Kitajima, I. Kubota, Y. Hirotsu, J. Wakimoto, M. Hollingsworth, S. Yonezawa (2007)
A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosisModern Pathology, 20
K. Kerr, Suzi Mackenzie, S. Ramasami, G. Murray, N. Fyfe, A. Chapman, M. Nicolson, G. King (2004)
Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinomaThe Journal of Pathology, 203
F. Bianchi, P. Nuciforo, M. Vecchi, L. Bernard, L. Tizzoni, A. Marchetti, F. Buttitta, L. Felicioni, F. Nicassio, P. Fiore (2007)
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes.The Journal of clinical investigation, 117 11
Rosane Achcar, M. Nikiforova, S. Yousem (2009)
Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.American journal of clinical pathology, 131 5
Chang-Qi Zhu, G. Santos, K. Ding, A. Sakurada, J. Cutz, Ni Liu, Tong Zhang, P. Marrano, M. Whitehead, J. Squire, S. Kamel‐Reid, L. Seymour, F. Shepherd, M. Tsao (2008)
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 26
Carla Kim, E. Jackson, Amber Woolfenden, Sharon Lawrence, I. Babar, Sinae Vogel, D. Crowley, R. Bronson, T. Jacks (2005)
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung CancerCell, 121
M. Okada, T. Koike, M. Higashiyama, Y. Yamato, K. Kodama, N. Tsubota (2006)
Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.The Journal of thoracic and cardiovascular surgery, 132 4
Z. Tang, L. Han, H. Lin, J. Cui, J. Jia, B. Low, Bao Li, Yu Chen (2007)
Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.Cancer research, 67 20
H. Sakurai, Y. Dobashi, E. Mizutani, H. Matsubara, Shoji Suzuki, K. Takano, S. Shindo, M. Matsumoto (2004)
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.The Annals of thoracic surgery, 78 5
S. Takashima, Y. Maruyama, M. Hasegawa, T. Yamanda, T. Honda, M. Kadoya, S. Sone (2003)
CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern.AJR. American journal of roentgenology, 180 3
T. Colby, I. Wistuba, A. Gazdar (1998)
Precursors to Pulmonary NeoplasiaAdvances in Anatomic Pathology, 5
Y. Nakatani, H. Kitamura, Y. Inayama, S. Kamijo, Y. Nagashima, K. Shimoyama, N. Nakamura, J. Sano, N. Ogawa, T. Shibagaki, M. Rešl, E. Mark (1998)
Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms.The American journal of surgical pathology, 22 4
H. Saito, Kouzo Yamada, N. Hamanaka, F. Oshita, H. Ito, H. Nakayama, T. Yokose, Y. Kameda, K. Noda (2009)
Initial Findings and Progression of Lung Adenocarcinoma on Serial Computed Tomography ScansJournal of Computer Assisted Tomography, 33
N. Sánchez-Mora, M. Presmanes, V. Monroy, N. Moreno, Jose Lara-Martínez, María Aladro, E. Álvarez‐Fernández (2008)
Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.Human pathology, 39 3
A. Inoue, K. Kobayashi, K. Usui, M. Maemondo, S. Okinaga, I. Mikami, M. Ando, K. Yamazaki, Y. Saijo, A. Gemma, H. Miyazawa, Tomoaki Tanaka, K. Ikebuchi, T. Nukiwa, S. Morita, K. Hagiwara (2009)
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 9
T. Hashizume, Kouzo Yamada, N. Okamoto, H. Saito, F. Oshita, Y. Kato, H. Ito, H. Nakayama, Y. Kameda, K. Noda (2008)
Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma.Chest, 133 2
C. Bryant, Daniel Albertus, Sinae Kim, Guoan Chen, C. Brambilla, M. Guedj, Chinatsu Arima, W. Travis, Y. Yatabe, Takashi Takahashi, E. Brambilla, D. Beer (2010)
Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation StudyPLoS ONE, 5
S. Aviel‐Ronen, Bradley Coe, S. Lau, G. Santos, Chang-Qi Zhu, D. Strumpf, I. Jurisica, W. Lam, M. Tsao (2008)
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar featuresProceedings of the National Academy of Sciences, 105
Souichi Oka, T. Hanagiri, H. Uramoto, T. Baba, M. Takenaka, M. Yasuda, K. Ono, T. So, M. Takenoyama, K. Yasumoto (2010)
Surgical resection for patients with mucinous bronchioloalveolar carcinoma.Asian journal of surgery, 33 2
H. Otani, S. Toyooka, J. Soh, H. Yamamoto, Hiroshi Suehisa, N. Kobayashi, H. Gobara, H. Mimura, K. Kiura, Y. Sano, S. Kanazawa, H. Date (2008)
Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC PatientsJournal of Thoracic Oncology, 3
N. Seki, T. Takasu, K. Mandai, M. Nakata, H. Saeki, Y. Heike, I. Takata, Y. Segawa, T. Hanafusa, K. Eguchi (2002)
Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 10
J. Pignon, H. Tribodet, G. Scagliotti, J. Douillard, F. Shepherd, R. Stephens, A. Dunant, V. Torri, R. Rosell, L. Seymour, S. Spiro, E. Rolland, R. Fossati, D. Aubert, K. Ding, D. Waller, T. Chevalier (2008)
Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 21
P. McMahon, C. Kong, M. Weinstein, A. Tramontano, L. Cipriano, B. Johnson, J. Weeks, G. Gazelle (2008)
Adopting helical CT screening for lung cancerCancer, 113
S. Savic, Coya Tapia, B. Grilli, A. Rufle, Michel Bihl, A. Barascud, M. Herzog, Luigi Terracciano, Florent Baty, L. Bubendorf (2007)
Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancersBritish Journal of Cancer, 98
H. Ishikawa, N. Koizumi, T. Morita, Y. Tani, M. Tsuchida, H. Umezu, M. Naito, K. Sasai (2005)
Ultrasmall Pulmonary Opacities on Multidetector-Row High-Resolution Computed Tomography: A Prospective Radiologic-Pathologic ExaminationJournal of Computer Assisted Tomography, 29
K. Tsuta, G. Ishii, J. Nitadori, Y. Murata, T. Kodama, K. Nagai, A. Ochiai (2006)
Comparison of the immunophenotypes of signet‐ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucinThe Journal of Pathology, 209
Nelson Ordóñez (2000)
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.The American journal of surgical pathology, 24 4
A. Horvath (2009)
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.Clinical chemistry, 55 5
M. Amin, S. Edge, F. Greene, D. Byrd, R. Brookland, M. Washington, J. Gershenwald, C. Compton, K. Hess, D. Sullivan, J. Jessup, J. Brierley, L. Gaspar, R. Schilsky, C. Balch, D. Winchester, Elliot Asare, M. Madera, Donna Gress, L. Meyer (2002)
AJCC Cancer Staging Manual
M. Wislez, M. Antoine, L. Baudrin, V. Poulot, A. Neuville, M. Pradere, E. Longchampt, Sylvie Isaac-Sibille, M. Lebitasy, J. Cadranel (2010)
Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.Lung cancer, 68 2
Y. Kojima, H. Saito, Y. Sakuma, T. Kondo, H. Ito, M. Tsuboi, F. Oshita, H. Nakayama, T. Yokose, Y. Kameda, K. Noda, Kouzo Yamada (2010)
Correlations of Thin-Section Computed Tomographic, Histopathological, and Clinical Findings of Adenocarcinoma With a Bubblelike AppearanceJournal of Computer Assisted Tomography, 34
A. Inoue, Takuji Suzuki, T. Fukuhara, M. Maemondo, Y. Kimura, N. Morikawa, H. Watanabe, Y. Saijo, T. Nukiwa (2006)
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 21
J. Boland, S. Erdoğan, G. Vasmatzis, Ping Yang, Lori Tillmans, Michele Johnson, Xiaoke Wang, Lisa Peterson, K. Halling, Andre Oliveira, M. Aubry, E. Yi (2009)
Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.Human pathology, 40 8
G. Rossi, B. Murer, A. Cavazza, L. Losi, P. Natali, A. Marchioni, M. Migaldi, G. Capitanio, E. Brambilla (2004)
Primary Mucinous (So-called Colloid) Carcinomas of the Lung: A Clinicopathologic and Immunohistochemical Study With Special Reference to CDX-2 Homeobox Gene and MUC2 ExpressionThe American Journal of Surgical Pathology, 28
M. Soda, Y. Choi, M. Enomoto, S. Takada, Y. Yamashita, S. Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, K. Kurashina, H. Hatanaka, M. Bando, S. Ohno, Y. Ishikawa, H. Aburatani, T. Niki, Y. Sohara, Y. Sugiyama, H. Mano (2007)
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 448
I. Zudaire, Lozano, Madeline Vazquez, M. Pajares, J. Agorreta, R. Pio, J. Zulueta, D. Yankelevitz, C. Henschke, L. Montuenga (2008)
Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates.Histology and histopathology, 23 1
P. Goldstraw, J. Crowley, K. Chansky, D. Giroux, P. Groome, R. Rami-Porta, P. Postmus, V. Rusch, L. Sobin (2007)
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2
Takehiro Watanabe, A. Okada, T. Imakiire, T. Koike, T. Hirono (2005)
Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration.The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 53 1
D. Chitale, Y. Gong, B. Taylor, S. Broderick, C. Brennan, R. Somwar, B. Golas, Lu Wang, N. Motoi, J. Szőke, J. Reinersman, John Major, C. Sander, V. Seshan, M. Zakowski, V. Rusch, W. Pao, W. Gerald, M. Ladanyi (2009)
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumorsOncogene, 28
D. Ettinger, G. Bepler, R. Bueno, Andrew Chang, Joe Chang, L. Chirieac, T. D’amico, T. Demmy, S. Feigenberg, F. Grannis, T. Jahan, M. Jahanzeb, A. Kessinger, R. Komaki, M. Kris, C. Langer, Q. Le, R. Martins, G. Otterson, F. Robert, D. Sugarbaker, D. Wood (2006)
Non-small cell lung cancer clinical practice guidelines in oncology.Journal of the National Comprehensive Cancer Network : JNCCN, 4 6
E. Lim, Shenli Zhang, Jia-liang Li, W. Yap, T. Howe, B. Tan, Yong-Shyan Lee, D. Wong, K. Khoo, K. Seto, L. Tan, T. Agasthian, H. Koong, J. Tam, C. Tan, Michael Caleb, A. Chang, A. Ng, P. Tan (2009)
Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)Journal of Thoracic Oncology, 4
J. Chang, Hui-ping Liu, M. Hsieh, Yueh-Fu Fang, Meng-Shu Hsieh, J. Hsieh, Yu-ting Chiu, Hsien‐Yu Tsai, Yi-Hsuan Chen, Ya-Ting Chen, Hui-Yu Hsu, Ying-Tsong Chen, S. Tsai, Yi-Rong Chen, B. Hsi, Shiu-Feng Huang (2008)
Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.Lung cancer, 61 3
Ha Kim, Y. Shim, K. Lee, Joungho Han, C. Yi, Y. Kim (2007)
Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.Radiology, 245 1
S. Sekine, T. Shibata, Y. Matsuno, Arafumi Maeshima, G. Ishii, M. Sakamoto, S. Hirohashi (2003)
β‐Catenin mutations in pulmonary blastomas: association with morule formationThe Journal of Pathology, 200
G. Darling, M. Allen, P. Decker, K. Ballman, R. Malthaner, R. Inculet, David Jones, R. Mckenna, R. Landreneau, V. Rusch, J. Putnam (2011)
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.The Journal of thoracic and cardiovascular surgery, 141 3
H. Sakamoto, J. Shimizu, Y. Horio, R. Ueda, Takashi Takahashi, T. Mitsudomi, Y. Yatabe (2007)
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomasThe Journal of Pathology, 212
J. Wang, S. Sone, L. Feng, Z. Yang, S. Takashima, Y. Maruyama, M. Hasegawa, S. Kawakami, T. Honda, T. Yamanda (2000)
Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features.The British journal of radiology, 73 873
K. Inamura, K. Takeuchi, Yuki Togashi, S. Hatano, H. Ninomiya, N. Motoi, M. Mun, Y. Sakao, S. Okumura, K. Nakagawa, M. Soda, Y. Choi, H. Mano, Y. Ishikawa (2009)
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onsetModern Pathology, 22
C. Henschke, D. Naidich, D. Yankelevitz, G. McGuinness, D. McCauley, James Smith, D. Libby, M. Pasmantier, M. Vázquez, J. Koizumi, D. Flieder, N. Altorki, O. Miettinen (2001)
Early Lung Cancer Action ProjectCancer, 92
D. Aberle, C. Berg, W. Black, T. Church, R. Fagerstrom, Barbara Galen, I. Gareen, C. Gatsonis, J. Goldin, J. Gohagan, B. Hillman, C. Jaffe, B. Kramer, D. Lynch, P. Marcus, M. Schnall, D. Sullivan, Dorothy Sullivan, C. Zylak (2011)
The National Lung Screening Trial: overview and study design.Radiology, 258 1
H. Schünemann, Roman Jaeschke, D. Cook, W. Bria, A. El‐Solh, A. Ernst, B. Fahy, M. Gould, Kathleen Horan, J. Krishnan, C. Manthous, J. Maurer, W. McNicholas, A. Oxman, G. Rubenfeld, G. Turino, G. Guyatt (2006)
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations.American journal of respiratory and critical care medicine, 174 5
T. Utsumi, N. Sawabata, M. Inoue, M. Okumura (2010)
Optimal sampling methods for margin cytology examination following lung excision.Interactive cardiovascular and thoracic surgery, 10 3
Ximing Tang, M. Varella-Garcia, A. Xavier, E. Massarelli, N. Ozburn, C. Moran, I. Wistuba (2008)
Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung AdenocarcinomasCancer Prevention Research, 1
F. Carey, W. Wallace, R. Fergusson, K. Kerr, D. Lamb (1992)
Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases.Thorax, 47
Joon Yim, Lee-Ching Zhu, L. Chiriboga, Heather Watson, J. Goldberg, A. Moreira (2007)
Histologic features are important prognostic indicators in early stages lung adenocarcinomasModern Pathology, 20
D. Wong, Elaine Leung, Kimpton So, Issan Tam, A. Sihoe, L. Cheng, Kwok‐Keung Ho, J. Au, L. Chung, Maria Wong (2009)
The EML4‐ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild‐type EGFR and KRASCancer, 115
K. Kamiya, Y. Hayashi, Junya Douguchi, A. Hashiguchi, Taketo Yamada, Y. Izumi, Masazumi Watanabe, M. Kawamura, H. Horinouchi, Naoki Shimada, Koichi Kobayashi, M. Sakamoto (2008)
Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinomaModern Pathology, 21
H. Miyake, A. Matsumoto, Akira Terada, Shintaro Yoshida, H. Takaki, H. Mori (1995)
Mucin‐producing Tumor of the Lung: CT FindingsJournal of Thoracic Imaging, 10
K. Kishi, S. Homma, A. Kurosaki, N. Motoi, T. Kohno, K. Nakata, K. Yoshimura (2004)
Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics.Lung cancer, 44 1
W. Travis, N. Rekhtman, G. Riley, K. Geisinger, H. Asamura, E. Brambilla, K. Garg, F. Hirsch, M. Noguchi, C. Powell, V. Rusch, G. Scagliotti, Y. Yatabe (2010)
Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 5 4
Binsheng Zhao, L. James, C. Moskowitz, P. Guo, M. Ginsberg, R. Lefkowitz, Yilin Qin, Gregory Riely, M. Kris, L. Schwartz (2009)
Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.Radiology, 252 1
H. Nakayama, S. Okumura, H. Daisaki, Y. Kato, H. Uehara, S. Adachi, M. Yoshimura, M. Okada (2010)
Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinomaCancer, 116
Ximing Tang, H. Shigematsu, B. Bekele, J. Roth, J. Minna, W. Hong, A. Gazdar, I. Wistuba (2005)
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.Cancer research, 65 17
A. Mujoomdar, J. Austin, Rohin Malhotra, C. Powell, G. Pearson, M. Shiau, H. Raftopoulos (2007)
Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.Radiology, 242 3
A. Borczuk, F. Qian, Angeliki Kazeros, J. Eleazar, A. Assaad, J. Sonett, M. Ginsburg, L. Gorenstein, C. Powell (2009)
Invasive Size is an Independent Predictor of Survival in Pulmonary AdenocarcinomaThe American Journal of Surgical Pathology, 33
E. Conde, Bárbara Angulo, M. Tang, M. Morente, J. Torres-Lanzas, A. Lopez-Encuentra, F. López-Rios, M. Sanchez-Cespedes (2006)
Molecular Context of the EGFR Mutations: Evidence for the Activation of mTOR/S6K SignalingClinical Cancer Research, 12
T. Berghmans, M. Paesmans, C. Mascaux, B. Martin, A. Meert, A. Haller, J. Lafitte, J. Sculier (2006)
Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.Annals of oncology : official journal of the European Society for Medical Oncology, 17 11
B. Martin, M. Paesmans, C. Mascaux, T. Berghmans, P. Lothaire, A. Meert, J. Lafitte, J. Sculier (2004)
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysisBritish Journal of Cancer, 91
Jian Yu, S. Kane, Jiong Wu, E. Benedettini, Dai-qiang Li, C. Reeves, Gregory Innocenti, Randy Wetzel, K. Crosby, A. Becker, Michelle Ferrante, W. Cheung, Xiqiang Hong, L. Chirieac, L. Sholl, H. Haack, Bradley Smith, R. Polakiewicz, Yi Tan, T. Gu, M. Loda, Xinmin Zhou, M. Comb (2009)
Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung CancerClinical Cancer Research, 15
Xiaoyan Wang, Mingsheng Wang, G. MacLennan, F. Abdul-Karim, J. Eble, T. Jones, F. Olobatuyi, R. Eisenberg, O. Cummings, Shaobo Zhang, A. López-Beltran, R. Montironi, Su-qin Zheng, Haiqun Lin, D. Davidson, Liang Cheng (2009)
Evidence for common clonal origin of multifocal lung cancers.Journal of the National Cancer Institute, 101 8
A. Shaw, B. Yeap, M. Mino‐Kenudson, S. Digumarthy, D. Costa, R. Heist, B. Solomon, Hannah Stubbs, S. Admane, U. McDermott, J. Settleman, Susumu Kobayashi, E. Mark, S. Rodig, L. Chirieac, E. Kwak, T. Lynch, A. Iafrate (2009)
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 26
Y. Yatabe, T. Mitsudomi, Takashi Takahashi (2002)
TTF-1 Expression in Pulmonary AdenocarcinomasThe American Journal of Surgical Pathology, 26
C. Huang, T. Taki, M. Adachi, T. Konishi, M. Higashiyama, M. Kinoshita, T. Hadama, M. Miyake (1998)
Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.International journal of oncology, 12 3
T. Miyoshi, Y. Satoh, S. Okumura, K. Nakagawa, T. Shirakusa, E. Tsuchiya, Y. Ishikawa (2003)
Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor PrognosisThe American Journal of Surgical Pathology, 27
Yang Jin-ji (2011)
Molecular Predictors of Outcome with Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer:Data from the Randomized Phase III INTEREST TrialJournal of Evidence-based Medicine
K. Naoki, Tzu-Hsiu Chen, W. Richards, D. Sugarbaker, M. Meyerson (2002)
Missense mutations of the BRAF gene in human lung adenocarcinoma.Cancer research, 62 23
M. Mino‐Kenudson, L. Chirieac, Kenny Law, J. Hornick, N. Lindeman, E. Mark, David Cohen, B. Johnson, P. Jänne, A. Iafrate, S. Rodig (2010)
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard ImmunohistochemistryClinical Cancer Research, 16
A. Potti, S. Mukherjee, R. Petersen, H. Dressman, A. Bild, J. Koontz, R. Kratzke, M. Watson, M. Kelley, G. Ginsburg, M. West, D. Harpole, J. Nevins (2006)
A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.The New England journal of medicine, 355 6
S. Edwards, C. Roberts, M. McKean, J. Cockburn, R. Jeffrey, K. Kerr (2000)
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell categoryJournal of Clinical Pathology, 53
M. Fukuoka, Yi-long Wu, S. Thongprasert, P. Sunpaweravong, S. Leong, V. Sriuranpong, T. Chao, K. Nakagawa, D. Chu, N. Saijo, E. Duffield, Y. Rukazenkov, G. Speake, Haiyi Jiang, A. Armour, K. To, J. Yang, T. Mok (2011)
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 21
B. Grønberg, R. Bremnes, O. Fløtten, T. Amundsen, P. Brunsvig, H. Hjelde, S. Kaasa, C. Plessen, Frøydis Stornes, T. Tollåli, F. Wammer, U. Aasebø, S. Sundstrøm (2009)
Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 19
K. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. André, V. Haddad, E. Taranchon, M. Filipits, R. Pirker, H. Popper, R. Stahel, L. Sabatier, J. Pignon, T. Tursz, T. Chevalier, J. Soria (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.The New England journal of medicine, 355 10
K. Takamochi, T. Ogura, Kenji Suzuki, H. Kawasaki, Y. Kurashima, T. Yokose, A. Ochiai, K. Nagai, Y. Nishiwaki, H. Esumi (2001)
Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.The American journal of pathology, 159 5
Y. Nonami, Y. Ohtuki, S. Sasaguri (2003)
Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.The Journal of cardiovascular surgery, 44 5
A. Marchetti, F. Buttitta, S. Pellegrini, A. Chella, G. Bertacca, Alberto Filardo, Vittorio Tognoni, Francesca Ferreli, Elena Signorini, C. Angeletti, G. Bevilacqua (1996)
BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K‐ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPEThe Journal of Pathology, 179
J.-A. Choi, J. Kim, K. Hong, H. Kim, Y. Oh, E. Kang (2000)
CT bronchus sign in malignant solitary pulmonary lesions: value in the prediction of cell typeEuropean Radiology, 10
Eun-Ah Park, H. Lee, Y. Kim, C. Kang, K. Kang, Y. Jeon, J. Goo, C. Lee, C. Park (2009)
EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: investigation of significantly related factors on CT, FDG-PET, and histopathology.Lung cancer, 64 2
M. Amin, P. Tamboli, S. Merchant, N. Ordóñez, J. Ro, A. Ayala, J. Ro (2002)
Micropapillary Component in Lung Adenocarcinoma: A Distinctive Histologic Feature With Possible Prognostic SignificanceThe American Journal of Surgical Pathology, 26
R. Shah, S. Badve, K. Papreddy, S. Schindler, W. Laskin, A. Yeldandi (2002)
Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.Human pathology, 33 9
S. Yousem, M. Nikiforova, Y. Nikiforov (2008)
The Histopathology of BRAF-V600E–mutated Lung AdenocarcinomaThe American Journal of Surgical Pathology, 32
M. Hasegawa, S. Sone, S. Takashima, F. Li, Z-g Yang, Y. Maruyama, T. Watanabe (2000)
Growth rate of small lung cancers detected on mass CT screening.The British journal of radiology, 73 876
Y. Sakao, T. Nakazono, S. Tomimitsu, Yuji Takeda, T. Sakuragi, M. Natsuaki, T. Itoh (2004)
Lung adenocarcinoma can be subtyped according to tumor dimension by computed tomography mediastinal-window setting. Additional size criteria for clinical T1 adenocarcinoma.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 26 6
Hisaaki Tanaka, K. Yanagisawa, Keiko Shinjo, A. Taguchi, K. Maeno, S. Tomida, Y. Shimada, H. Osada, T. Kosaka, H. Matsubara, T. Mitsudomi, Y. Sekido, M. Tanimoto, Y. Yatabe, Takashi Takahashi (2007)
Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.Cancer research, 67 13
G. Guyatt, A. Oxman, G. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H. Schünemann (2008)
GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ : British Medical Journal, 336
H. Sohn, You-Jung Yang, J. Ryu, S. Oh, K. Im, D. Moon, Dae-Ho Lee, C. Suh, Jung-shin Lee, Sang-We Kim (2008)
[18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the LungClinical Cancer Research, 14
K. Shedden, Jeremy Taylor, S. Enkemann, M. Tsao, T. Yeatman, W. Gerald, S. Eschrich, I. Jurisica, T. Giordano, David Misek, A. Chang, Changyun Zhu, D. Strumpf, S. Hanash, F. Shepherd, K. Ding, L. Seymour, K. Naoki, N. Pennell, B. Weir, R. Verhaak, C. Ladd-Acosta, T. Golub, M. Gruidl, Anupama Sharma, J. Szőke, M. Zakowski, V. Rusch, M. Kris, A. Viale, N. Motoi, W. Travis, B. Conley, V. Seshan, M. Meyerson, R. Kuick, K. Dobbin, T. Lively, James Jacobson, D. Beer (2008)
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 14
D. Ionescu, D. Treaba, C. Gilks, S. Leung, D. Renouf, J. Laskin, R. Wood-Baker, A. Gown (2007)
Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic SignificanceThe American Journal of Surgical Pathology, 31
Lan Guo, Yan Ma, Rebecca Ward, V. Castranova, Xianglin Shi, Y. Qian (2006)
Constructing Molecular Classifiers for the Accurate Prognosis of Lung AdenocarcinomaClinical Cancer Research, 12
(2009)
Grading of lung adenocarcinoma: architectural versus nuclear approach
B. Wang, J. Gil, D. Kaufman, L. Gan, D. Kohtz, D. Burstein (2002)
P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.Human pathology, 33 9
J. Vansteenkiste, Bruno Belie, G. Deneffe, M. Demedts, P. Leyn, D. raemdonck, T. Lerut (2001)
Practical approach to patients presenting with multiple synchronous suspect lung lesions: a reflection on the current TNM classification based on 54 cases with complete follow-up.Lung cancer, 34 2
S. Um, Hojoong Kim, W. Koh, G. Suh, M. Chung, J. Choi, Joungho Han, Kyung-Soo Lee, Jhingook Kim (2009)
Prognostic Value of 18F-FDG Uptake on Positron Emission Tomography in Patients with Pathologic Stage I Non-small Cell Lung CancerJournal of Thoracic Oncology, 4
W. Travis, T. Colby, B. Corrin, Y. Shimosato, E. Brambilla (1999)
Histological Typing of Lung and Pleural Tumours
B. Weir, M. Woo, G. Getz, S. Perner, L. Ding, R. Beroukhim, William Lin, M. Province, A. Kraja, L. Johnson, K. Shah, Mitsuo Sato, Roman Thomas, J. Barletta, I. Borecki, S. Broderick, A. Chang, Derek Chiang, L. Chirieac, Jeonghee Cho, Y. Fujii, A. Gazdar, T. Giordano, H. Greulich, M. Hanna, B. Johnson, M. Kris, A. Lash, Ling Lin, N. Lindeman, E. Mardis, J. McPherson, J. Minna, M. Morgan, M. Nadel, M. Orringer, John Osborne, B. Ozenberger, A. Ramos, James Robinson, J. Roth, V. Rusch, H. Sasaki, F. Shepherd, C. Sougnez, M. Spitz, M. Tsao, David Twomey, R. Verhaak, G. Weinstock, D. Wheeler, W. Winckler, A. Yoshizawa, Soyoung Yu, M. Zakowski, Qunyuan Zhang, D. Beer, I. Wistuba, M. Watson, L. Garraway, M. Ladanyi, W. Travis, W. Pao, M. Rubin, S. Gabriel, R. Gibbs, H. Varmus, R. Wilson, E. Lander, M. Meyerson (2007)
Characterizing the cancer genome in lung adenocarcinomaNature, 450
C. Casali, G. Rossi, A. Marchioni, G. Sartori, Federica Maselli, L. Longo, Emilia Tallarico, U. Morandi (2010)
A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular Features, and Possible Pitfalls in Routine PracticeJournal of Thoracic Oncology, 5
K. Ohtsuka, H. Ohnishi, G. Furuyashiki, H. Nogami, Y. Koshiishi, Akiko Ooide, S. Matsushima, Takashi Watanabe, T. Goya (2006)
Clinico-Pathological and Biological Significance of Tyrosine Kinase Domain Gene Mutations and Overexpression of Epidermal Growth Factor Receptor for Lung AdenocarcinomaJournal of Thoracic Oncology, 1
Rebecca Lindell, T. Hartman, S. Swensen, J. Jett, D. Midthun, H. Tazelaar, J. Mandrekar (2007)
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.Radiology, 242 2
A. Sandler, R. Gray, M. Perry, J. Brahmer, J. Schiller, A. Dowlati, R. Lilenbaum, David Johnson (2006)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.The New England journal of medicine, 355 24
L. Sholl, B. Yeap, A. Iafrate, Alison Holmes-Tisch, Yi-Ping Chou, Ming-Tsang Wu, Y. Goan, L. Su, E. Benedettini, Jian Yu, M. Loda, P. Jänne, D. Christiani, L. Chirieac (2009)
Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.Cancer research, 69 21
K. Nguyen, Susumu Kobayashi, D. Costa (2009)
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.Clinical lung cancer, 10 4
G. Guyatt, A. Oxman, E. Akl, R. Kunz, G. Vist, J. Brożek, S. Norris, Y. Falck-Ytter, P. Glasziou, H. DeBeer, Roman Jaeschke, D. Rind, J. Meerpohl, P. Dahm, H. Schünemann (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.Journal of clinical epidemiology, 64 4
Y. Sakairi, T. Nakajima, K. Yasufuku, D. Ikebe, H. Kageyama, M. Soda, K. Takeuchi, M. Itami, T. Iizasa, I. Yoshino, H. Mano, H. Kimura (2010)
EML4-ALK Fusion Gene Assessment Using Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle AspirationClinical Cancer Research, 16
Arafumi Maeshima, M. Sakamoto, S. Hirohashi (2002)
Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K-ras gene mutationVirchows Archiv, 440
D. Lau, Bangjie Yang, Ruide Hu, J. Benfield (1997)
Clonal Origin of Multiple Lung Cancers: K‐ras and p53 Mutations Determined by Nonradioisotopic Single‐strand Conformation Polymorphism AnalysisDiagnostic Molecular Pathology, 6
J. Licchesi, W. Westra, C. Hooker, E. Machida, S. Baylin, J. Herman (2008)
Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.Carcinogenesis, 29 5
A. Kawahara, C. Yamamoto, Kazutaka Nakashima, K. Azuma, S. Hattori, Masaki Kashihara, H. Aizawa, Y. Basaki, M. Kuwano, M. Kage, T. Mitsudomi, M. Ono (2010)
Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical AnalysisClinical Cancer Research, 16
M. Roh, J. Lee, P. Choi, Y. Hong (2004)
Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage I lung adenocarcinomaHistopathology, 45
Jin-Haeng Chung, G. Choe, S. Jheon, S. Sung, T. Kim, K. Lee, Jae Lee, C. Lee (2009)
Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary SpreadJournal of Thoracic Oncology, 4
G. Scagliotti, P. Parikh, J. Pawel, B. Biesma, J. Vansteenkiste, C. Manegold, P. Serwatowski, U. Gatzemeier, R. Digumarti, M. Zukin, J. Lee, A. Mellemgaard, Keunchil Park, S. Patil, J. Rolski, T. Goksel, F. Marinis, L. Simms, K. Sugarman, D. Gandara (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 21
M. Gaeta, S. Vinci, F. Minutoli, S. Mazziotti, G. Ascenti, I. Salamone, S. Lamberto, A. Blandino (2002)
CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: pictorial reviewEuropean Radiology, 12
N. Seki, S. Sawada, M. Nakata, Takeshi Inoue, R. Nishimura, Y. Segawa, Reishi Shibakuki, K. Eguchi (2008)
Lung Cancer with Localized Ground-Glass Attenuation Represents Early-Stage Adenocarcinoma in NonsmokersJournal of Thoracic Oncology, 3
Issan Tam, L. Chung, W. Suen, E. Wang, May Wong, Kok Ho, W. Lam, S. Chiu, L. Girard, J. Minna, A. Gazdar, M. Wong (2006)
Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic FeaturesClinical Cancer Research, 12
G. Bepler (2009)
Are we coming full circle for lung cancer screening a second time?American journal of respiratory and critical care medicine, 180 5
H. Macmahon, J. Austin, G. Gamsu, C. Herold, J. Jett, D. Naidich, E. Patz, S. Swensen (2005)
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.Radiology, 237 2
Xiaozhu Zhang, Yi Zhao, Miao Wang, W. Yap, A. Chang (2008)
Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer.Lung cancer, 60 2
H. Terasaki, T. Niki, Y. Matsuno, T. Yamada, Arafumi Maeshima, H. Asamura, N. Hayabuchi, S. Hirohashi (2003)
Lung Adenocarcinoma With Mixed Bronchioloalveolar and Invasive Components: Clinicopathological Features, Subclassification by Extent of Invasive Foci, and Immunohistochemical CharacterizationThe American Journal of Surgical Pathology, 27
O. Kaufmann, M. Dietel (2000)
Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and BHistopathology, 36
(1967)
Typing of Lung Tumours. Geneva: World Health Organization (WHO)
K. Nakanishi (1990)
Alveolar epithelial hyperplasia and adenocarcinoma of the lung.Archives of pathology & laboratory medicine, 114 4
Katsuaki Sato, Y. Ueda, H. Shikata, S. Katsuda (2006)
Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.Pathology, research and practice, 202 10
S. Dacic, Yongli Shuai, S. Yousem, P. Ohori, M. Nikiforova (2010)
Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomasModern Pathology, 23
J. Ravenel, W. Leue, P. Nietert, James Miller, Katherine Taylor, G. Silvestri (2008)
Pulmonary nodule volume: effects of reconstruction parameters on automated measurements--a phantom study.Radiology, 247 2
D. Beer, S. Kardia, Chiang-Ching Huang, T. Giordano, A. Levin, David Misek, Lin Lin, Guoan Chen, Tarek Gharib, Dafydd Thomas, Michelle Lizyness, R. Kuick, S. Hayasaka, Jeremy Taylor, M. Iannettoni, M. Orringer, S. Hanash (2002)
Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 8
P. Boyle, B. Levin (2009)
World Cancer Report 2008
T. Kosaka, Y. Yatabe, Ryoichi Onozato, H. Kuwano, T. Mitsudomi (2009)
Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung AdenocarcinomaJournal of Thoracic Oncology, 4
C. Zwirewich, S. Vedal, R. Miller, N. Müller (1991)
Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation.Radiology, 179 2
G. Scagliotti, Keunchil Park, S. Patil, J. Rolski, T. Goksel, R. Martins, S. Gans, C. Visseren-Grul, P. Peterson (2009)
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.European journal of cancer, 45 13
K. Nakanishi, T. Kawai, Fumiyuki Kumaki, Sadayuki Hirot, M. Mukai, E. Ikeda (2002)
Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung.Human pathology, 33 7
G. Guyatt, A. Oxman, R. Kunz, Y. Falck-Ytter, G. Vist, A. Liberati, H. Schünemann (2008)
Going from evidence to recommendationsBMJ : British Medical Journal, 336
Allan Li, D. Chitale, Gregory Riely, W. Pao, V. Miller, M. Zakowski, V. Rusch, M. Kris, M. Ladanyi (2008)
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.The Journal of molecular diagnostics : JMD, 10 3
T. Aoki, Yoshinori Tomoda, Hideyuki Watanabe, H. Nakata, T. Kasai, Hiroshi Hashimoto, M. Kodate, T. Osaki, K. Yasumoto (2001)
Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival.Radiology, 220 3
K. Kubota, S. Niho, S. Enatsu, Y. Nambu, Y. Nishiwaki, N. Saijo, M. Fukuoka (2009)
Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II StudyJournal of Thoracic Oncology, 4
H. Linardou, I. Dahabreh, D. Kanaloupiti, F. Siannis, D. Bafaloukos, P. Kosmidis, C. Papadimitriou, S. Murray (2008)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.The Lancet. Oncology, 9 10
N. Rekhtman, Suzanne Brandt, C. Sigel, M. Friedlander, Gregory Riely, W. Travis, M. Zakowski, A. Moreira (2011)
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular TestingJournal of Thoracic Oncology, 6
K. Schmid, Natalie Oehl, F. Wrba, R. Pirker, C. Pirker, M. Filipits (2009)
EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node MetastasesClinical Cancer Research, 15
Boming Dong, Masami Sato, M. Sagawa, C. Endo, K. Usuda, A. Sakurada, Shulin Wu, T. Oyaizu, I. Ishida, M. Handa, T. Kondo (2002)
Computed tomographic image comparison between mediastinal and lung windows provides possible prognostic information in patients with small peripheral lung adenocarcinoma.The Journal of thoracic and cardiovascular surgery, 124 5
C. Mascaux, B. Martin, M. Paesmans, T. Berghmans, M. Dusart, A. Haller, P. Lothaire, A. Meert, J. Lafitte, J. Sculier (2006)
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsBritish Journal of Cancer, 95
(2010)
Available at: www.surveymonkey.com
C. Mascaux, N. Iannino, B. Martin, M. Paesmans, T. Berghmans, Michèle Dusart, A. Haller, P. Lothaire, A. Meert, S. Noël, J. Lafitte, J. Sculier (2004)
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisBritish Journal of Cancer, 92
F. Detterbeck, M. Jantz, M. Wallace, J. Vansteenkiste, G. Silvestri (2007)
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).Chest, 132 3 Suppl
A. Hata, N. Katakami, S. Fujita, R. Kaji, Y. Imai, Yutaka Takahashi, T. Nishimura, K. Tomii, K. Ishihara (2010)
Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar CarcinomaJournal of Thoracic Oncology, 5
K. Kodama, M. Higashiyama, H. Yokouchi, K. Takami, K. Kuriyama, M. Mano, T. Nakayama (2001)
Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning.Lung cancer, 33 1
H. Kimura, Y. Fujiwara, T. Sone, H. Kunitoh, T. Tamura, K. Kasahara, Kazuto Nishio (2006)
EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinibBritish Journal of Cancer, 95
W. Pao, W. Pao, W. Pao, M. Kris, M. Kris, A. Iafrate, M. Ladanyi, P. Jänne, I. Wistuba, R. Miake-Lye, R. Herbst, D. Carbone, B. Johnson, T. Lynch (2009)
Integration of Molecular Profiling into the Lung Cancer ClinicClinical Cancer Research, 15
Y. Sakuma, S. Matsukuma, M. Yoshihara, Yoshiyasu Nakamura, K. Noda, H. Nakayama, Y. Kameda, E. Tsuchiya, Y. Miyagi (2007)
Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.American journal of clinical pathology, 128 1
B. Martin, M. Paesmans, T. Berghmans, F. Branle, L. Ghisdal, C. Mascaux, A. Meert, E. Steels, F. Vallot, J. Verdebout, J. Lafitte, J. Sculier (2003)
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisBritish Journal of Cancer, 89
F. Hirsch, M. Varella-Garcia, J. Mccoy, H. West, A. Xavier, P. Gumerlock, P. Bunn, W. Franklin, J. Crowley, D. Gandara (2005)
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 28
B. Hoop, H. Gietema, Saskia Vorst, K. Murphy, R. Klaveren, M. Prokop (2010)
Pulmonary ground-glass nodules: increase in mass as an early indicator of growth.Radiology, 255 1
H. Yabuuchi, S. Murayama, J. Murakami, N. Hashiguchi, H. Soeda, K. Sugio, K. Masuda (2000)
High-resolution CT characteristics of poorly differentiated adenocarcinoma of the peripheral lung: comparison with well differentiated adenocarcinoma.Radiation medicine, 18 6
Hong Li, Lindsay Schmidt, J. Greenson, A. Chang, J. Myers (2009)
Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.American journal of clinical pathology, 131 1
A. Hansen, N. Martini, S. Spiro, N. Martini (1988)
Lung Tumors
J. Licchesi, W. Westra, C. Hooker, J. Herman (2008)
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the LungClinical Cancer Research, 14
C. Castro, Dona Coffey, L. Medeiros, P. Cagle (2001)
Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung.Annals of diagnostic pathology, 5 5
C. Park, J. Goo, T. Kim, Hyun Lee, K. Lee, C. Lee, Y. Kim, Kwang Kim, Ho Lee, Eun-Ah Park, J. Im (2008)
Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions?Chest, 133 6
V. Miller, M. Kris, N. Shah, J. Patel, C. Azzoli, Jorge Gomez, L. Krug, W. Pao, N. Rizvi, B. Pizzo, L. Tyson, E. Venkatraman, L. Ben-Porat, N. Memoli, M. Zakowski, V. Rusch, R. Heelan (2004)
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 6
W. Travis, E. Brambilla, H. Müller-hermelink (2004)
Pathology and genetics of tumours of the lung , pleura, thymus and heart
©1999 Cancer Research Campaign Article no. bjoc.1998.0247 Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation
G. Gordon, W. Richards, D. Sugarbaker, M. Jaklitsch, R. Bueno (2003)
A prognostic test for adenocarcinoma of the lung from gene expression profiling data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 12 9
F. Cloran, Kevin Banks, Won Song, Young Kim, Y. Bradley (2010)
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.Lung cancer, 68 1
R. Rami-Porta, C. Wittekind, P. Goldstraw (2005)
Complete resection in lung cancer surgery: proposed definition.Lung cancer, 49 1
Ryu Jokoji, Takashi Yamasaki, S. Minami, K. Komuta, Y. Sakamaki, K. Takeuchi, M. Tsujimoto (2010)
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinomaJournal of Clinical Pathology, 63
Haruhiko Nakamura, N. Kawasaki, M. Taguchi, K. Kabasawa (2005)
Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysisBritish Journal of Cancer, 92
N. Hanna (2007)
Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene MutationsYearbook of Oncology, 2007
I. Petersen, W. Kotb, Karl-Heinz Friedrich, K. Schlüns, A. Böcking, M. Dietel (2009)
Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters.Lung cancer, 65 3
E. Kwak, Y. Bang, D. Camidge, A. Shaw, B. Solomon, Robert Maki, Sai-Hong Ou, Bruce Dezube, P. Jänne, Daniel, B. Costa, M. Varella-Garcia, W. Kim, Thomas Lynch, P. Fidias, Hannah Stubbs, J. Engelman, V. Lecia, Sequist, Weiwei Tan, L. Gandhi, M. Mino‐Kenudson, Greg Wei, S. Shreeve, M. Ratain, Jeffrey, Settleman, James Christensen, D. Haber, K. Wilner, R. Salgia, Geoffrey Shapiro, J. Clark, A. Iafrate (2010)
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.The New England journal of medicine, 363 18
M. Mori, Sudha Rao, H. Popper, P. Cagle, A. Fraire (2001)
Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the LungModern Pathology, 14
V. Holst, S. Finkelstein, S. Yousem (1998)
Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease.The American journal of surgical pathology, 22 11
Giovanni Tonon, Cameron Brennan, A. Protopopov, Gautam Maulik, Bin Feng, Yunyu Zhang, Deepak Khatry, Mingjian You, Andrew Aguirre, Eric Martin, Z. Yang, Hongbin Ji, Lynda Chin, Kwok-Kin Wong, Ronald DePinho (2005)
Common and contrasting genomic profiles among the major human lung cancer subtypes.Cold Spring Harbor symposia on quantitative biology, 70
G. Rossi, G. Pelosi, P. Graziano, M. Barbareschi, M. Papotti (2009)
Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized TreatmentsInternational Journal of Surgical Pathology, 17
Y. Sakao, T. Nakazono, T. Sakuragi, M. Natsuaki, T. Itoh (2004)
Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung.The Annals of thoracic surgery, 77 4
A. Marchetti, C. Martella, L. Felicioni, Fabio Barassi, S. Salvatore, A. Chella, P. Camplese, T. Iarussi, F. Mucilli, A. Mezzetti, F. Cuccurullo, R. Sacco, F. Buttitta (2005)
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 4
W. Pao, Theresa Wang, Gregory Riely, V. Miller, Qiulu Pan, M. Ladanyi, M. Zakowski, R. Heelan, M. Kris, H. Varmus (2005)
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPLoS Medicine, 2
K. Chansky, J. Sculier, J. Crowley, D. Giroux, J. Meerbeeck, P. Goldstraw (2009)
The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung CancerJournal of Thoracic Oncology, 4
S. Lau, D. Luthringer, R. Eisen (2002)
Thyroid Transcription Factor-1: A ReviewApplied Immunohistochemistry & Molecular Morphology, 10
K. Higashi, Y. Ueda, M. Yagishita, Y. Arisaka, A. Sakurai, M. Oguchi, H. Seki, Y. Nambu, H. Tonami, I. Yamamoto (2000)
FDG PET measurement of the proliferative potential of non-small cell lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 41 1
P. Chu, Emerald Wu, L. Weiss (2000)
Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesModern Pathology, 13
L. Kreyberg (1971)
Lung tumours.Journal of Clinical Pathology, 24
K. Inamura, Y. Satoh, S. Okumura, K. Nakagawa, E. Tsuchiya, M. Fukayama, Y. Ishikawa (2005)
Pulmonary Adenocarcinomas With Enteric Differentiation: Histologic and Immunohistochemical Characteristics Compared With Metastatic Colorectal Cancers and Usual Pulmonary AdenocarcinomasThe American Journal of Surgical Pathology, 29
G. Rossi, M. Papotti, M. Barbareschi, P. Graziano, G. Pelosi (2009)
Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 28
D. Berrar, Brian Sturgeon, I. Bradbury, C. Downes, W. Dubitzky (2005)
Survival Trees for Analyzing Clinical Outcome in Lung Adenocarcinomas Based on Gene Expression Profiles: Identification of Neogenin and Diacylglycerol Kinase Expression as Critical FactorsJournal of computational biology : a journal of computational molecular cell biology, 12 5
C. Zwirewich, R. Miller, N. Müller (1990)
Multicentric adenocarcinoma of the lung: CT-pathologic correlation.Radiology, 176 1
N. Goldstein, A. Mani, G. Chmielewski, R. Welsh, S. Pursel (1999)
Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung.American journal of clinical pathology, 112 3
S. Takashima, Y. Maruyama, M. Hasegawa, A. Saito, M. Haniuda, M. Kadoya (2003)
High-Resolution CT Features: Prognostic Significance in Peripheral Lung Adenocarcinoma with Bronchioloalveolar Carcinoma ComponentsRespiration, 70
Y. Makimoto, K. Nabeshima, H. Iwasaki, T. Miyoshi, S. Enatsu, T. Shiraishi, A. Iwasaki, T. Shirakusa, M. Kikuchi (2005)
Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours)Histopathology, 46
W. Sterlacci, M. Fiegl, W. Hilbe, J. Auberger, G. Mikuz, A. Tzankov (2009)
Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected casesVirchows Archiv, 455
R. Nakahara, T. Yokose, K. Nagai, Y. Nishiwaki, A. Ochiai (2001)
Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasiaThorax, 56
(2010)
Signet ring cell features (SRCF) in lung adenocarcinoma: a cytologic feature or a histologic subtype
M. Hiramatsu, Takuya Inagaki, Tomoya Inagaki, Y. Matsui, Y. Satoh, S. Okumura, Y. Ishikawa, Etsuo Miyaoka, K. Nakagawa (2008)
Pulmonary Ground-Glass Opacity (GGO) Lesions–Large Size and a History of Lung Cancer are Risk Factors for GrowthJournal of Thoracic Oncology, 3
Y. Choi, M. Soda, Y. Yamashita, Toshihide Ueno, Junpei Takashima, T. Nakajima, Y. Yatabe, K. Takeuchi, T. Hamada, H. Haruta, Y. Ishikawa, H. Kimura, T. Mitsudomi, Y. Tanio, H. Mano (2010)
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.The New England journal of medicine, 363 18
A. Nicholson, D. Gonzalez, P. Shah, Matthew Pynegar, Manjiri Deshmukh, A. Rice, S. Popat (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation AnalysisJournal of Thoracic Oncology, 5
K. Inamura, K. Takeuchi, Yuki Togashi, K. Nomura, H. Ninomiya, M. Okui, Y. Satoh, S. Okumura, K. Nakagawa, M. Soda, Young Choi, T. Niki, H. Mano, Y. Ishikawa (2008)
EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung CancersJournal of Thoracic Oncology, 3
S. Monaco, M. Nikiforova, K. Cieply, L. Teot, W. Khalbuss, S. Dacic (2010)
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.Human pathology, 41 1
S-G. Wu, C. Gow, C-J. Yu, Y-L. Chang, C-H Yang, Yi-Chiung Hsu, J. Shih, Y-C Lee, P. Yang (2008)
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinomaEuropean Respiratory Journal, 32
Myungsook Chang, J. Ahn, Jeeyun Lee, Kyoungha Kim, Yeon-Hee Park, Joungho Han, M. Ahn, Keunchil Park (2010)
The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer.Lung cancer, 69 3
D. Hansell, A. Bankier, H. Macmahon, T. McLoud, N. Müller, J. Remy (2008)
Fleischner Society: glossary of terms for thoracic imaging.Radiology, 246 3
D. Hayes, S. Monti, G. Parmigiani, C. Gilks, K. Naoki, Arindam Bhattacharjee, M. Socinski, C. Perou, M. Meyerson (2006)
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 31
N. Goldstein, M. Thomas (2001)
Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.American journal of clinical pathology, 116 3
H. Nomori, K. Iwatani, Hironori Kobayashi, A. Mori, Shouichi Yoshioka (2006)
Omission of mediastinal lymph node dissection in lung cancer: its techniques and diagnostic procedures.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 12 2
D. Finley, A. Yoshizawa, W. Travis, Qin Zhou, V. Seshan, M. Bains, R. Flores, N. Rizk, V. Rusch, Bernard Park (2007)
Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung CancersJournal of Thoracic Oncology, 5
P. Loo, Stuart Thomas, M. Nicolson, M. Fyfe, K. Kerr (2010)
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy SpecimensJournal of Thoracic Oncology, 5
K. Takamochi, K. Nagai, J. Yoshida, Kenji Suzuki, Y. Ohde, M. Nishimura, S. Sasaki, Y. Nishiwaki (2001)
Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.The Journal of thoracic and cardiovascular surgery, 122 2
C. Azzoli, Sherman Baker, S. Temin, W. Pao, Timothy Aliff, J. Brahmer, David Johnson, J. Laskin, G. Masters, D. Milton, L. Nordquist, D. Pfister, S. Piantadosi, J. Schiller, Reily Smith, Thomas Smith, John Strawn, D. Trent, G. Giaccone (2009)
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 36
M. Godoy, D. Naidich (2009)
Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management.Radiology, 253 3
Zhifu Sun, D. Wigle, Ping Yang (2008)
Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 6
Chun-Ta Huang, R. Yen, M. Cheng, Y-C Hsu, Pin-Fei Wei, Yi-Ju Tsai, Meng-Feng Tsai, J. Shih, Chih‐Hsin Yang, Pan‐Chyr Yang (2010)
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinomaMedical Oncology, 27
Xizhong Sui, Changqing Gao (2013)
The angiotensinogen gene M235T polymorphism and acute myocardial infarction risk: a meta-analysis of 22 studiesMolecular Biology Reports, 40
S. Rodig, M. Mino‐Kenudson, S. Dacic, B. Yeap, A. Shaw, J. Barletta, Hannah Stubbs, Kenny Law, N. Lindeman, E. Mark, P. Janne, T. Lynch, B. Johnson, A. Iafrate, L. Chirieac (2009)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western PopulationClinical Cancer Research, 15
H. Sakurai, Arafumi Maeshima, Shun-ichi Watanabe, Kenji Suzuki, R. Tsuchiya, A. Maeshima, Y. Matsuno, H. Asamura (2004)
Grade of Stromal Invasion in Small Adenocarcinoma of the Lung: Histopathological Minimal Invasion and PrognosisThe American Journal of Surgical Pathology, 28
B. Adler, S. Padley, R. Miller, N. Müller (1992)
High-resolution CT of bronchioloalveolar carcinoma.AJR. American journal of roentgenology, 159 2
(2010)
Characteristic morphology and immunoprofile of lung adenocarcinoma with KRAS mutations: propensity for solid growth pattern and correlation with TTF-1 expression
J. Higginson (1968)
International Agency for Research on Cancer.WHO chronicle, 22 12
K. Higashi, Y. Ueda, H. Seki, Kokichi Yuasa, M. Oguchi, Tetsuhiko Noguchi, M. Taniguchi, H. Tonami, T. Okimura, I. Yamamoto (1998)
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 39 6
T. Koga, S. Hashimoto, K. Sugio, Y. Yonemitsu, Y. Nakashima, I. Yoshino, Y. Matsuo, S. Mojtahedzadeh, K. Sugimachi, K. Sueishi (2002)
Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.American journal of clinical pathology, 117 3
H. Ninomiya, M. Hiramatsu, K. Inamura, K. Nomura, M. Okui, T. Miyoshi, S. Okumura, Y. Satoh, K. Nakagawa, M. Nishio, T. Horai, S. Miyata, E. Tsuchiya, M. Fukayama, Y. Ishikawa (2009)
Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type.Lung cancer, 63 2
Y. Nakazato, Y. Minami, Hiromi Kobayashi, K. Satomi, Y. Anami, K. Tsuta, R. Tanaka, Masafumi Okada, T. Goya, M. Noguchi (2010)
Nuclear grading of primary pulmonary adenocarcinomasCancer, 116
Ho Lee, K. Lee, Joungho Han, Byung‐Tae Kim, Y. Cho, Y. Shim, Jhingook Kim (2009)
Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons.Lung cancer, 65 2
Hitoshi Kitamura, Yoichi Kameda, N. Nakamura, Yoshiaki Inayama, Yukio Nakatani, T. Shibagaki, Takaaki Ito, H. Hayashi, Hirokazu Kimura, Masayoshi Kanisawa (1996)
Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen.The American journal of surgical pathology, 20 5
S. Takashima, S. Sone, Feng Li, Y. Maruyama, M. Hasegawa, T. Matsushita, F. Takayama, M. Kadoya (2003)
Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: Reliable high-resolution CT features of benign lesions.AJR. American journal of roentgenology, 180 4
F. Clayton (1986)
Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlatesCancer, 57
C. Mao, Li-xin Qiu, Ru-yan Liao, Fang-Bing Du, Hong Ding, Wanshan Yang, Jin Li, Qing Chen (2010)
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.Lung cancer, 69 3
Hongye Liu, A. Kho, I. Kohane, Yao Sun (2006)
Predicting Survival within the Lung Cancer Histopathological Hierarchy Using a Multi-Scale Genomic Model of DevelopmentPLoS Medicine, 3
S. Oda, K. Awai, K. Murao, Akio Ozawa, Y. Yanaga, Koichi Kawanaka, Y. Yamashita (2010)
Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT.AJR. American journal of roentgenology, 194 2
S. Niho, Tomoyuki Yokose, Kenji Suzuki, T. Kodama, Yutaka Nishiwaki, Kiyoshi Mukai (1999)
Monoclonality of atypical adenomatous hyperplasia of the lung.The American journal of pathology, 154 1
H. Vesselle, É. Turcotte, L. Wiens, E. Vallières, D. Wood (2008)
Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation IndexJournal of Thoracic Oncology, 3
A. Yoshida, K. Tsuta, Shun-ichi Watanabe, I. Sekine, M. Fukayama, H. Tsuda, K. Furuta, T. Shibata (2011)
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.Lung cancer, 72 3
Y. Kim, G. Ishii, K. Goto, K. Nagai, K. Tsuta, S. Shiono, J. Nitadori, T. Kodama, Y. Nishiwaki, A. Ochiai (2004)
Dominant Papillary Subtype Is a Significant Predictor of the Response to Gefitinib in Adenocarcinoma of the LungClinical Cancer Research, 10
A. Borczuk, L. Shah, G. Pearson, Kristin Walter, Liqun Wang, J. Austin, R. Friedman, C. Powell (2004)
Molecular signatures in biopsy specimens of lung cancer.American journal of respiratory and critical care medicine, 170 2
Hirokazu Awaya, Y. Takeshima, M. Yamasaki, K. Inai (2004)
Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.American journal of clinical pathology, 121 5
H. Asamura, Kenji Suzuki, Shun-ichi Watanabe, Y. Matsuno, Arafumi Maeshima, R. Tsuchiya (2003)
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.The Annals of thoracic surgery, 76 4
F. Clayton (1988)
The spectrum and significance of bronchioloalveolar carcinomas.Pathology annual, 23 Pt 2
H. West, D. Garfield (2009)
Bronchioloalveolar carcinoma: not as easy as "BAC".Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 4 9
S. Khayyata, Shine Yun, T. Pasha, Bo Jian, C. McGrath, Gordon Yu, Prabodh Gupta, Z. Baloch (2009)
Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine‐needle aspiration specimensDiagnostic Cytopathology, 37
N. Kobayashi, S. Toyooka, J. Soh, K. Ichimura, H. Yanai, Hiroshi Suehisa, Shuji Ichihara, M. Yamane, M. Aoe, Y. Sano, H. Date (2007)
Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or LessJournal of Thoracic Oncology, 2
S. Jennings, H. Winer-Muram, R. Tarver, M. Farber (2004)
Lung tumor growth: assessment with CT--comparison of diameter and cross-sectional area with volume measurements.Radiology, 231 3
G. Bepler, I. Kusmartseva, Swati Sharma, A. Gautam, A. Cantor, Anupama Sharma, G. Simon (2006)
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 29
T. Kawakami, K. Nabeshima, Y. Makimoto, M. Hamasaki, A. Iwasaki, T. Shirakusa, H. Iwasaki (2007)
Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factorsModern Pathology, 20
C. Chung, R. Zaino, J. Stryker, M. O'Neill, W. Demuth (1982)
Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis.The Annals of thoracic surgery, 33 6
M. Okada, W. Nishio, T. Sakamoto, K. Uchino, K. Hanioka, C. Ohbayashi, N. Tsubota (2004)
Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas.The Journal of thoracic and cardiovascular surgery, 127 3
N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R. Stephens, A. Okamoto, J. Yokota, Tadao Tanaka, G. Calin, Chang-gong Liu, C. Croce, C. Harris (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.Cancer cell, 9 3
Y. Yatabe, T. Mitsudomi (2007)
Epidermal growth factor receptor mutations in lung cancersPathology International, 57
D. Yankelevitz, A. Reeves, W. Kostis, Binsheng Zhao, C. Henschke (2000)
Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation.Radiology, 217 1
D. Gandara (2006)
Bronchioloalveolar carcinoma: the "changing face of lung cancer".Clinical lung cancer, 7 5
Zu-hua Gao, S. Urbanski (2005)
The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature.American journal of clinical pathology, 124 1
K. Kodama, M. Higashiyama, H. Yokouchi, K. Takami, K. Kuriyama, Y. Kusunoki, T. Nakayama, F. Imamura (2002)
Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years.The Annals of thoracic surgery, 73 2
M. Zakowski, S. Hussain, W. Pao, M. Ladanyi, M. Ginsberg, R. Heelan, V. Miller, V. Rusch, M. Kris (2009)
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.Archives of pathology & laboratory medicine, 133 3
Y. Kim, Tae-You Kim, Dong Lee, Sun Park, Ju-Yeon Park, S. Seo, H. Choi, H. Kang, S. Hahn, C. Kang, S. Sung, Joo Kim (2008)
Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.Lung cancer, 59 1
M. Akira, S. Atagi, M. Kawahara, K. Iuchi, T. Johkoh (1999)
High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients.AJR. American journal of roentgenology, 173 6
S. Yamada, T. Kohno (2004)
Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter.The Annals of thoracic surgery, 77 6
S. Yousem (2005)
Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical studyModern Pathology, 18
H. Shigematsu, Li Lin, Takao Takahashi, M. Nomura, Makoto Suzuki, I. Wistuba, K. Fong, Hue Lee, S. Toyooka, N. Shimizu, T. Fujisawa, Ziding Feng, J. Roth, J. Herz, J. Minna, A. Gazdar (2006)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.Journal of the National Cancer Institute, 97 5
J. Sculier, K. Chansky, J. Crowley, J. Meerbeeck, P. Goldstraw (2008)
The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th EditionJournal of Thoracic Oncology, 3
D. Raz, A. Odisho, B. Franc, D. Jablons (2006)
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.The Journal of thoracic and cardiovascular surgery, 132 5
T. Kohno, H. Kunitoh, Kenji Suzuki, Seiichiro Yamamoto, A. Kuchiba, Y. Matsuno, N. Yanagitani, J. Yokota (2008)
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.Carcinogenesis, 29 5
A. Marchetti, S. Pellegrini, G. Bertacca, F. Buttitta, Patrizia Gaeta, V. Carnicelli, V. Nardini, P. Griseri, A. Chella, C. Angeletti, G. Bevilacqua (1998)
FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K‐ras mutationsThe Journal of Pathology, 184
Toshiyuki Takeuchi, S. Tomida, Y. Yatabe, T. Kosaka, H. Osada, K. Yanagisawa, T. Mitsudomi, Takashi Takahashi (2006)
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 11
Haruhiko Nakamura, N. Kawasaki, M. Taguchi, K. Kabasawa (2005)
Association of HER‐2 overexpression with prognosis in nonsmall cell lung carcinoma: A metaanalysisCancer, 103
T. Miyoshi, T. Shirakusa, Y. Ishikawa, A. Iwasaki, T. Shiraishi, Y. Makimoto, H. Iwasaki, K. Nabeshima (2005)
Possible mechanism of metastasis in lung adenocarcinomas with a micropapillary patternPathology International, 55
T. Yan, D. Black, P. Bannon, B. McCaughan (2009)
Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15
K. Takeuchi, Y. Choi, Yuki Togashi, M. Soda, S. Hatano, K. Inamura, S. Takada, Toshihide Ueno, Y. Yamashita, Y. Satoh, S. Okumura, K. Nakagawa, Y. Ishikawa, H. Mano (2009)
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung CancerClinical Cancer Research, 15
M. Cohen, J. Gootenberg, P. Keegan, R. Pazdur (2007)
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.The oncologist, 12 6
(2009)
IASLC Staging Manual in Thoracic Oncology. Orange Park, FL: International Association for the Study of Lung Cancer, Editorial
M. Infante, S. Cavuto, F. Lutman, G. Brambilla, G. Chiesa, G. Ceresoli, Eliseo Passera, E. Angeli, M. Chiarenza, G. Aranzulla, U. Cariboni, V. Errico, F. Inzirillo, E. Bottoni, E. Voulaz, M. Alloisio, A. Destro, M. Roncalli, A. Santoro, G. Ravasi (2009)
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.American journal of respiratory and critical care medicine, 180 5
G. Oxnard, L. Schwartz (2010)
Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survivalCancer, 116
H. Sasaki, O. Kawano, K. Endo, E. Suzuki, H. Haneda, H. Yukiue, Y. Kobayashi, M. Yano, Y. Fujii (2006)
Uncommon V599E BRAF mutations in Japanese patients with lung cancer.The Journal of surgical research, 133 2
T. Yokose, Kenji Suzuki, K. Nagai, Y. Nishiwaki, S. Sasaki, A. Ochiai (2000)
Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter.Lung cancer, 29 3
M. Higashiyama, K. Kodama, K. Takami, N. Higaki, T. Nakayama, H. Yokouchi (2003)
Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer.The Journal of thoracic and cardiovascular surgery, 125 1
T. Shibata, S. Hanada, A. Kokubu, Y. Matsuno, H. Asamura, T. Ohta, M. Sakamoto, S. Hirohashi (2007)
Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinomaCancer Science, 98
T. Koike, K. Togashi, T. Shirato, Seijiro Sato, H. Hirahara, M. Sugawara, F. Oguma, H. Usuda, I. Emura (2009)
Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination.The Annals of thoracic surgery, 88 4
W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, Bhuvanesh Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, Doris Kupfer, R. Wilson, M. Kris, H. Varmus (2004)
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.Proceedings of the National Academy of Sciences of the United States of America, 101 36
I. Yoshino, R. Nakanishi, M. Kodate, T. Osaki, T. Hanagiri, M. Takenoyama, T. Yamashita, H. Imoto, S. Taga, K. Yasumoto (2000)
Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection.International surgery, 85 2
C. Savci-Heijink, F. Kosari, M. Aubry, B. Caron, Zhifu Sun, Ping Yang, G. Vasmatzis (2009)
The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.The American journal of pathology, 174 5
Y. Yamato, M. Tsuchida, Takehiro Watanabe, T. Aoki, N. Koizumi, H. Umezu, J. Hayashi (2001)
Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung.The Annals of thoracic surgery, 71 3
Y. Janjigian, K. McDonnell, M. Kris, R. Shen, C. Sima, N. Rizvi, Gregory Riely (2008)
Pack years of cigarette smoking as a predictor of survival in 2,013 patients with stage IIIb/IV non-small cell lung cancer (NSCLC)Journal of Clinical Oncology, 26
T. Ohtsuka, Kenichi Watanabe, M. Kaji, T. Naruke, K. Suemasu (2006)
A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 30 1
H. West, W. Franklin, J. Mccoy, P. Gumerlock, R. Vance, D. Lau, K. Chansky, J. Crowley, D. Gandara (2006)
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 12
M. Sonobe, T. Manabe, H. Wada, F. Tanaka (2005)
Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinomaBritish Journal of Cancer, 93
R. Kakinuma, H. Ohmatsu, M. Kaneko, M. Kusumoto, J. Yoshida, K. Nagai, Y. Nishiwaki, Toshiaki Kobayashi, R. Tsuchiya, H. Nishiyama, E. Matsui, K. Eguchi, N. Moriyama (2004)
Progression of Focal Pure Ground-Glass Opacity Detected by Low-Dose Helical Computed Tomography Screening for Lung CancerJournal of Computer Assisted Tomography, 28
M. Brevet, M. Arcila, M. Ladanyi (2010)
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.The Journal of molecular diagnostics : JMD, 12 2
R. Saad, P. Cho, J. Silverman, Yulin Liu (2004)
Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.American journal of clinical pathology, 122 3
M. Copin, M. Buisine, E. Leteurtre, C. Marquette, H. Porte, J. Aubert, B. Gosselin, N. Porchet (2001)
Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas.Human pathology, 32 3
STATE OF THE ART:CONCISE REVIEW International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma William D. Travis, MD, Elisabeth Brambilla, MD, Masayuki Noguchi, MD, Andrew G. Nicholson, MD, Kim R. Geisinger, MD, Yasushi Yatabe, MD, David G. Beer, PhD, Charles A. Powell, MD, Gregory J. Riely, MD, Paul E. Van Schil, MD, Kavita Garg, MD, John H. M. Austin, MD, Hisao Asamura, MD, Valerie W. Rusch, MD, Fred R. Hirsch, MD, Giorgio Scagliotti, MD, Tetsuya Mitsudomi, MD, Rudolf M. Huber, MD, Yuichi Ishikawa, MD, James Jett, MD, Montserrat Sanchez-Cespedes, PhD, Jean-Paul Sculier, MD, Takashi Takahashi, MD, Masahiro Tsuboi, MD, Johan Vansteenkiste, MD, Ignacio Wistuba, MD, Pan-Chyr Yang, MD, Denise Aberle, MD, Christian Brambilla, MD, Douglas Flieder, MD, Wilbur Franklin, MD, Adi Gazdar, MD, Michael Gould, MD, MS, Philip Hasleton, MD, Douglas Henderson, MD, Bruce Johnson, MD, David Johnson, MD, Keith Kerr, MD, Keiko Kuriyama, MD, Jin Soo Lee, MD, Vincent A. Miller, MD, Iver Petersen, MD, PhD, Victor Roggli, MD, Rafael Rosell, MD, Nagahiro Saijo, MD, Erik Thunnissen, MD, Ming Tsao, MD, and David Yankelewitz, MD systematic review was performed under the guidance of the American Introduction: Adenocarcinoma is the
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Feb 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.